activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2147273	CHEMBL921863	Activity of human GRK6 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	110.0	CHEMBL6144	Homo sapiens	Activity	%	110.0
	2147273	CHEMBL921863	Activity of human GRK6 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	110.0	CHEMBL6144	Homo sapiens	Activity	%	110.0
	2721618	CHEMBL1057446	Inhibition of GRK6 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL6144	Homo sapiens	INH	%	50.0
	3052622	CHEMBL1038408	Residual activity of GRK6 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	93.0	CHEMBL6144	Homo sapiens	Residual activity	%	93.0
	3053931	CHEMBL1046823	Residual activity of GRK6 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	104.0	CHEMBL6144	Homo sapiens	Residual activity	%	104.0
	3054183	CHEMBL1040651	Residual activity of GRK6 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	79.0	CHEMBL6144	Homo sapiens	Residual activity	%	79.0
	3055470	CHEMBL1038408	Residual activity of GRK6 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	80.0	CHEMBL6144	Homo sapiens	Residual activity	%	80.0
	3056775	CHEMBL1046823	Residual activity of GRK6 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	91.0	CHEMBL6144	Homo sapiens	Residual activity	%	91.0
	3057027	CHEMBL1040651	Residual activity of GRK6 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	88.0	CHEMBL6144	Homo sapiens	Residual activity	%	88.0
	3058347	CHEMBL1038408	Residual activity of GRK6 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	90.0	CHEMBL6144	Homo sapiens	Residual activity	%	90.0
	3058599	CHEMBL1046823	Residual activity of GRK6 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	105.0	CHEMBL6144	Homo sapiens	Residual activity	%	105.0
	3072945	CHEMBL1040651	Residual activity of GRK6 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	88.0	CHEMBL6144	Homo sapiens	Residual activity	%	88.0
	3212634	CHEMBL1106960	Inhibition of GRK6-mediated bovine tubulin phosphorylation by scintillation counting	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	IC50	nM	490.0	CHEMBL6144	Homo sapiens	IC50	nM	490.0
	3224834	CHEMBL1100485	Inhibition of GRK6 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL6144	Homo sapiens	INH	%	50.0
	3225084	CHEMBL1100485	Inhibition of GRK6 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL6144	Homo sapiens	INH	%	50.0
	3443409	CHEMBL1244442	Inhibition of GRK6 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	-2.0	CHEMBL6144	Homo sapiens	INH	%	-2.0
	3443626	CHEMBL1244442	Inhibition of GRK6 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	2.0	CHEMBL6144	Homo sapiens	INH	%	2.0
	3444781	CHEMBL1244442	Inhibition of GRK6 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	1.0	CHEMBL6144	Homo sapiens	INH	%	1.0
	3445405	CHEMBL1244442	Inhibition of GRK6 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	0.0	CHEMBL6144	Homo sapiens	INH	%	0.0
	3445622	CHEMBL1244442	Inhibition of GRK6 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	9.0	CHEMBL6144	Homo sapiens	INH	%	9.0
	3445830	CHEMBL1244442	Inhibition of GRK6 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	6.0	CHEMBL6144	Homo sapiens	INH	%	6.0
	3446020	CHEMBL1244442	Inhibition of GRK6 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	5.0	CHEMBL6144	Homo sapiens	INH	%	5.0
	3463243	CHEMBL1252431	Inhibition of GRK6 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	78.0	CHEMBL6144	Homo sapiens	INH	%	78.0
	3463787	CHEMBL1252431	Inhibition of GRK6 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	27.0	CHEMBL6144	Homo sapiens	INH	%	27.0
	3464006	CHEMBL1252431	Inhibition of GRK6 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	2.0	CHEMBL6144	Homo sapiens	INH	%	2.0
	5120404	CHEMBL1645977	Inhibition of human GRK6 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	108.0	CHEMBL6144	Homo sapiens	INH	%	108.0
	7959787	CHEMBL1932868	Inhibition of GRK6	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL6144	Homo sapiens	IC50	uM	30.0
	7959788	CHEMBL1932868	Inhibition of GRK6	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL6144	Homo sapiens	IC50	uM	30.0
	8061221	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.28	CHEMBL6144	Homo sapiens	Inhibition	%	-0.28
	8061398	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-0.64	CHEMBL6144	Homo sapiens	Inhibition	%	-0.64
	8061622	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	6.26	CHEMBL6144	Homo sapiens	Inhibition	%	6.26
	8061729	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.65	CHEMBL6144	Homo sapiens	Inhibition	%	2.65
	8062144	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	6.18	CHEMBL6144	Homo sapiens	Inhibition	%	6.18
	8062260	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.53	CHEMBL6144	Homo sapiens	Inhibition	%	3.53
	8062646	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	7.2	CHEMBL6144	Homo sapiens	Inhibition	%	7.2
	8062968	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.14	CHEMBL6144	Homo sapiens	Inhibition	%	0.14
	8063100	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.98	CHEMBL6144	Homo sapiens	Inhibition	%	-0.98
	8063491	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	9.79	CHEMBL6144	Homo sapiens	Inhibition	%	9.79
	8063599	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.64	CHEMBL6144	Homo sapiens	Inhibition	%	0.64
	8063823	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	5.54	CHEMBL6144	Homo sapiens	Inhibition	%	5.54
	8064005	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	-1.22	CHEMBL6144	Homo sapiens	Inhibition	%	-1.22
	8064120	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.0	CHEMBL6144	Homo sapiens	Inhibition	%	4.0
	8064344	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.82	CHEMBL6144	Homo sapiens	Inhibition	%	0.82
	8064554	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-1.42	CHEMBL6144	Homo sapiens	Inhibition	%	-1.42
	8064692	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-1.81	CHEMBL6144	Homo sapiens	Inhibition	%	-1.81
	8064916	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-1.23	CHEMBL6144	Homo sapiens	Inhibition	%	-1.23
	8065082	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	5.32	CHEMBL6144	Homo sapiens	Inhibition	%	5.32
	8065422	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	4.28	CHEMBL6144	Homo sapiens	Inhibition	%	4.28
	8065597	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	-2.46	CHEMBL6144	Homo sapiens	Inhibition	%	-2.46
	8065936	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.85	CHEMBL6144	Homo sapiens	Inhibition	%	2.85
	8066146	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.76	CHEMBL6144	Homo sapiens	Inhibition	%	-0.76
	8066506	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	0.91	CHEMBL6144	Homo sapiens	Inhibition	%	0.91
	8066672	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	9.55	CHEMBL6144	Homo sapiens	Inhibition	%	9.55
	8067020	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	6.2	CHEMBL6144	Homo sapiens	Inhibition	%	6.2
	8067195	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	-1.79	CHEMBL6144	Homo sapiens	Inhibition	%	-1.79
	8067540	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.75	CHEMBL6144	Homo sapiens	Inhibition	%	0.75
	8067750	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-2.13	CHEMBL6144	Homo sapiens	Inhibition	%	-2.13
	8068109	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	-0.01	CHEMBL6144	Homo sapiens	Inhibition	%	-0.01
	8068273	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	5.37	CHEMBL6144	Homo sapiens	Inhibition	%	5.37
	8068497	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	8.61	CHEMBL6144	Homo sapiens	Inhibition	%	8.61
	8068622	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.85	CHEMBL6144	Homo sapiens	Inhibition	%	2.85
	8068796	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	-0.49	CHEMBL6144	Homo sapiens	Inhibition	%	-0.49
	8069020	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	-3.74	CHEMBL6144	Homo sapiens	Inhibition	%	-3.74
	8069145	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.76	CHEMBL6144	Homo sapiens	Inhibition	%	-0.76
	8069440	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	2.78	CHEMBL6144	Homo sapiens	Inhibition	%	2.78
	8069825	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	7.71	CHEMBL6144	Homo sapiens	Inhibition	%	7.71
	8069951	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	4.08	CHEMBL6144	Homo sapiens	Inhibition	%	4.08
	8070347	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	-0.39	CHEMBL6144	Homo sapiens	Inhibition	%	-0.39
	8070472	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-1.41	CHEMBL6144	Homo sapiens	Inhibition	%	-1.41
	8070696	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.19	CHEMBL6144	Homo sapiens	Inhibition	%	-0.19
	8070770	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	3.87	CHEMBL6144	Homo sapiens	Inhibition	%	3.87
	8070994	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	2.28	CHEMBL6144	Homo sapiens	Inhibition	%	2.28
	8071151	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	11.04	CHEMBL6144	Homo sapiens	Inhibition	%	11.04
	8071277	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.46	CHEMBL6144	Homo sapiens	Inhibition	%	0.46
	8071501	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	3.16	CHEMBL6144	Homo sapiens	Inhibition	%	3.16
	8071674	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	-0.71	CHEMBL6144	Homo sapiens	Inhibition	%	-0.71
	8072023	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-1.28	CHEMBL6144	Homo sapiens	Inhibition	%	-1.28
	8072104	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.52	CHEMBL6144	Homo sapiens	Inhibition	%	-0.52
	8072337	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.3	CHEMBL6144	Homo sapiens	Inhibition	%	0.3
	8072494	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.76	CHEMBL6144	Homo sapiens	Inhibition	%	3.76
	8072843	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.42	CHEMBL6144	Homo sapiens	Inhibition	%	-0.42
	8073010	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	-0.55	CHEMBL6144	Homo sapiens	Inhibition	%	-0.55
	8073359	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-1.53	CHEMBL6144	Homo sapiens	Inhibition	%	-1.53
	8073702	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-1.05	CHEMBL6144	Homo sapiens	Inhibition	%	-1.05
	8073935	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-2.28	CHEMBL6144	Homo sapiens	Inhibition	%	-2.28
	8074087	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	10.76	CHEMBL6144	Homo sapiens	Inhibition	%	10.76
	8074441	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.69	CHEMBL6144	Homo sapiens	Inhibition	%	0.69
	8074598	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-1.33	CHEMBL6144	Homo sapiens	Inhibition	%	-1.33
	8074822	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-0.72	CHEMBL6144	Homo sapiens	Inhibition	%	-0.72
	8074949	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.14	CHEMBL6144	Homo sapiens	Inhibition	%	-0.14
	8075284	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-3.25	CHEMBL6144	Homo sapiens	Inhibition	%	-3.25
	8075521	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.02	CHEMBL6144	Homo sapiens	Inhibition	%	-0.02
	8075662	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	4.67	CHEMBL6144	Homo sapiens	Inhibition	%	4.67
	8075886	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	8.66	CHEMBL6144	Homo sapiens	Inhibition	%	8.66
	8076028	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.28	CHEMBL6144	Homo sapiens	Inhibition	%	-0.28
	8076400	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	-2.45	CHEMBL6144	Homo sapiens	Inhibition	%	-2.45
	8076534	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.02	CHEMBL6144	Homo sapiens	Inhibition	%	-0.02
	8076860	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-1.04	CHEMBL6144	Homo sapiens	Inhibition	%	-1.04
	8077107	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	1.13	CHEMBL6144	Homo sapiens	Inhibition	%	1.13
	8077459	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.81	CHEMBL6144	Homo sapiens	Inhibition	%	2.81
	8077610	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.33	CHEMBL6144	Homo sapiens	Inhibition	%	1.33
	8077834	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	1.08	CHEMBL6144	Homo sapiens	Inhibition	%	1.08
	8077977	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	-0.33	CHEMBL6144	Homo sapiens	Inhibition	%	-0.33
	8078116	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-2.35	CHEMBL6144	Homo sapiens	Inhibition	%	-2.35
	8078340	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.57	CHEMBL6144	Homo sapiens	Inhibition	%	-0.57
	8078442	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.43	CHEMBL6144	Homo sapiens	Inhibition	%	0.43
	8078692	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	1.51	CHEMBL6144	Homo sapiens	Inhibition	%	1.51
	8079032	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.91	CHEMBL6144	Homo sapiens	Inhibition	%	3.91
	8079414	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	4.23	CHEMBL6144	Homo sapiens	Inhibition	%	4.23
	8079556	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.78	CHEMBL6144	Homo sapiens	Inhibition	%	3.78
	8079919	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	16.27	CHEMBL6144	Homo sapiens	Inhibition	%	16.27
	8080024	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-2.74	CHEMBL6144	Homo sapiens	Inhibition	%	-2.74
	8080248	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	2.15	CHEMBL6144	Homo sapiens	Inhibition	%	2.15
	8080276	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	1.33	CHEMBL6144	Homo sapiens	Inhibition	%	1.33
	8080500	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	10.09	CHEMBL6144	Homo sapiens	Inhibition	%	10.09
	8080615	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.69	CHEMBL6144	Homo sapiens	Inhibition	%	1.69
	8081003	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.3	CHEMBL6144	Homo sapiens	Inhibition	%	-0.3
	8081138	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-2.01	CHEMBL6144	Homo sapiens	Inhibition	%	-2.01
	8081362	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.01	CHEMBL6144	Homo sapiens	Inhibition	%	1.01
	8081506	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	58.79	CHEMBL6144	Homo sapiens	Inhibition	%	58.79
	8081833	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.0	CHEMBL6144	Homo sapiens	Inhibition	%	1.0
	8082085	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-0.4	CHEMBL6144	Homo sapiens	Inhibition	%	-0.4
	8082198	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	5.27	CHEMBL6144	Homo sapiens	Inhibition	%	5.27
	8082422	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.6	CHEMBL6144	Homo sapiens	Inhibition	%	1.6
	8082595	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.28	CHEMBL6144	Homo sapiens	Inhibition	%	1.28
	8082942	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.27	CHEMBL6144	Homo sapiens	Inhibition	%	1.27
	8083098	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.79	CHEMBL6144	Homo sapiens	Inhibition	%	5.79
	8083421	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.58	CHEMBL6144	Homo sapiens	Inhibition	%	1.58
	8083675	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	2.07	CHEMBL6144	Homo sapiens	Inhibition	%	2.07
	8084009	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.25	CHEMBL6144	Homo sapiens	Inhibition	%	2.25
	8084194	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	-2.97	CHEMBL6144	Homo sapiens	Inhibition	%	-2.97
	8084536	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.25	CHEMBL6144	Homo sapiens	Inhibition	%	3.25
	8084697	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	16.29	CHEMBL6144	Homo sapiens	Inhibition	%	16.29
	8084921	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	8.47	CHEMBL6144	Homo sapiens	Inhibition	%	8.47
	8085019	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-0.72	CHEMBL6144	Homo sapiens	Inhibition	%	-0.72
	8085275	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-3.93	CHEMBL6144	Homo sapiens	Inhibition	%	-3.93
	8085607	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.34	CHEMBL6144	Homo sapiens	Inhibition	%	2.34
	8085796	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	15.75	CHEMBL6144	Homo sapiens	Inhibition	%	15.75
	8086020	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	-1.62	CHEMBL6144	Homo sapiens	Inhibition	%	-1.62
	8086135	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.36	CHEMBL6144	Homo sapiens	Inhibition	%	3.36
	8086521	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	20.14	CHEMBL6144	Homo sapiens	Inhibition	%	20.14
	8086620	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.85	CHEMBL6144	Homo sapiens	Inhibition	%	0.85
	8086844	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-3.7	CHEMBL6144	Homo sapiens	Inhibition	%	-3.7
	8087055	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	4.35	CHEMBL6144	Homo sapiens	Inhibition	%	4.35
	8087213	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.21	CHEMBL6144	Homo sapiens	Inhibition	%	4.21
	8087551	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.46	CHEMBL6144	Homo sapiens	Inhibition	%	2.46
	8087689	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-0.78	CHEMBL6144	Homo sapiens	Inhibition	%	-0.78
	8087913	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-2.07	CHEMBL6144	Homo sapiens	Inhibition	%	-2.07
	8088055	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	9.53	CHEMBL6144	Homo sapiens	Inhibition	%	9.53
	8088427	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.69	CHEMBL6144	Homo sapiens	Inhibition	%	1.69
	8088555	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	0.89	CHEMBL6144	Homo sapiens	Inhibition	%	0.89
	8088872	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	-3.25	CHEMBL6144	Homo sapiens	Inhibition	%	-3.25
	8089224	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.87	CHEMBL6144	Homo sapiens	Inhibition	%	1.87
	8089372	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	3.06	CHEMBL6144	Homo sapiens	Inhibition	%	3.06
	8089716	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	2.4	CHEMBL6144	Homo sapiens	Inhibition	%	2.4
	8089896	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.24	CHEMBL6144	Homo sapiens	Inhibition	%	-0.24
	8090120	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-3.85	CHEMBL6144	Homo sapiens	Inhibition	%	-3.85
	8090285	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	26.54	CHEMBL6144	Homo sapiens	Inhibition	%	26.54
	8090452	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.41	CHEMBL6144	Homo sapiens	Inhibition	%	3.41
	8090676	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.49	CHEMBL6144	Homo sapiens	Inhibition	%	0.49
	8090815	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-5.14	CHEMBL6144	Homo sapiens	Inhibition	%	-5.14
	8091020	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.01	CHEMBL6144	Homo sapiens	Inhibition	%	3.01
	8091381	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	6.79	CHEMBL6144	Homo sapiens	Inhibition	%	6.79
	8091536	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.82	CHEMBL6144	Homo sapiens	Inhibition	%	3.82
	8091760	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	-0.46	CHEMBL6144	Homo sapiens	Inhibition	%	-0.46
	8091876	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.95	CHEMBL6144	Homo sapiens	Inhibition	%	3.95
	8092237	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.13	CHEMBL6144	Homo sapiens	Inhibition	%	1.13
	8092388	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	6.28	CHEMBL6144	Homo sapiens	Inhibition	%	6.28
	8092760	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.48	CHEMBL6144	Homo sapiens	Inhibition	%	1.48
	8092889	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	2.39	CHEMBL6144	Homo sapiens	Inhibition	%	2.39
	8093113	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-0.3	CHEMBL6144	Homo sapiens	Inhibition	%	-0.3
	8093201	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.18	CHEMBL6144	Homo sapiens	Inhibition	%	1.18
	8093425	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	-2.71	CHEMBL6144	Homo sapiens	Inhibition	%	-2.71
	8093565	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-1.09	CHEMBL6144	Homo sapiens	Inhibition	%	-1.09
	8093704	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	8.62	CHEMBL6144	Homo sapiens	Inhibition	%	8.62
	8093928	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	2.0	CHEMBL6144	Homo sapiens	Inhibition	%	2.0
	8094048	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-0.11	CHEMBL6144	Homo sapiens	Inhibition	%	-0.11
	8094452	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl	Outside typical range	CHEMBL1909353	=	Inhibition	%	-36.95	CHEMBL6144	Homo sapiens	Inhibition	%	-36.95
	8094627	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	3.9	CHEMBL6144	Homo sapiens	Inhibition	%	3.9
	8095007	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	4.06	CHEMBL6144	Homo sapiens	Inhibition	%	4.06
	8095147	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-2.97	CHEMBL6144	Homo sapiens	Inhibition	%	-2.97
	8095350	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.33	CHEMBL6144	Homo sapiens	Inhibition	%	3.33
	8095574	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.67	CHEMBL6144	Homo sapiens	Inhibition	%	1.67
	8095715	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	31.41	CHEMBL6144	Homo sapiens	Inhibition	%	31.41
	8096087	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.17	CHEMBL6144	Homo sapiens	Inhibition	%	2.17
	8096204	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.08	CHEMBL6144	Homo sapiens	Inhibition	%	3.08
	8096428	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.94	CHEMBL6144	Homo sapiens	Inhibition	%	3.94
	8096567	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.03	CHEMBL6144	Homo sapiens	Inhibition	%	-0.03
	8096723	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	6.32	CHEMBL6144	Homo sapiens	Inhibition	%	6.32
	8096947	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.49	CHEMBL6144	Homo sapiens	Inhibition	%	5.49
	8097094	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.31	CHEMBL6144	Homo sapiens	Inhibition	%	1.31
	8097625	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	-1.66	CHEMBL6144	Homo sapiens	Inhibition	%	-1.66
	8097775	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.69	CHEMBL6144	Homo sapiens	Inhibition	%	-0.69
	8098132	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.77	CHEMBL6144	Homo sapiens	Inhibition	%	-0.77
	8098252	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.1	CHEMBL6144	Homo sapiens	Inhibition	%	0.1
	8098476	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.82	CHEMBL6144	Homo sapiens	Inhibition	%	0.82
	8098656	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.04	CHEMBL6144	Homo sapiens	Inhibition	%	-0.04
	8098841	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	14.35	CHEMBL6144	Homo sapiens	Inhibition	%	14.35
	8099209	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	12.07	CHEMBL6144	Homo sapiens	Inhibition	%	12.07
	8099351	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	-0.96	CHEMBL6144	Homo sapiens	Inhibition	%	-0.96
	8099575	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.01	CHEMBL6144	Homo sapiens	Inhibition	%	0.01
	8099769	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	2.24	CHEMBL6144	Homo sapiens	Inhibition	%	2.24
	8099916	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.73	CHEMBL6144	Homo sapiens	Inhibition	%	4.73
	8100286	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-0.25	CHEMBL6144	Homo sapiens	Inhibition	%	-0.25
	8100626	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-0.24	CHEMBL6144	Homo sapiens	Inhibition	%	-0.24
	8100766	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.12	CHEMBL6144	Homo sapiens	Inhibition	%	1.12
	8101150	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.53	CHEMBL6144	Homo sapiens	Inhibition	%	5.53
	8101292	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-1.02	CHEMBL6144	Homo sapiens	Inhibition	%	-1.02
	8101701	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.35	CHEMBL6144	Homo sapiens	Inhibition	%	0.35
	8101954	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	-7.11	CHEMBL6144	Homo sapiens	Inhibition	%	-7.11
	8102109	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-0.32	CHEMBL6144	Homo sapiens	Inhibition	%	-0.32
	8102464	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.87	CHEMBL6144	Homo sapiens	Inhibition	%	1.87
	8102808	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-2.36	CHEMBL6144	Homo sapiens	Inhibition	%	-2.36
	8102986	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	4.75	CHEMBL6144	Homo sapiens	Inhibition	%	4.75
	8103182	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.82	CHEMBL6144	Homo sapiens	Inhibition	%	2.82
	8103406	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	5.48	CHEMBL6144	Homo sapiens	Inhibition	%	5.48
	8103544	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	2.83	CHEMBL6144	Homo sapiens	Inhibition	%	2.83
	8103918	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.06	CHEMBL6144	Homo sapiens	Inhibition	%	0.06
	8104103	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-1.85	CHEMBL6144	Homo sapiens	Inhibition	%	-1.85
	8104251	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.93	CHEMBL6144	Homo sapiens	Inhibition	%	5.93
	8104475	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	4.28	CHEMBL6144	Homo sapiens	Inhibition	%	4.28
	8104621	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.71	CHEMBL6144	Homo sapiens	Inhibition	%	2.71
	8104959	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.68	CHEMBL6144	Homo sapiens	Inhibition	%	2.68
	8105099	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.19	CHEMBL6144	Homo sapiens	Inhibition	%	-0.19
	8105323	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.67	CHEMBL6144	Homo sapiens	Inhibition	%	0.67
	8105489	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	4.79	CHEMBL6144	Homo sapiens	Inhibition	%	4.79
	8105627	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.02	CHEMBL6144	Homo sapiens	Inhibition	%	-0.02
	8105851	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	0.04	CHEMBL6144	Homo sapiens	Inhibition	%	0.04
	8105907	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.81	CHEMBL6144	Homo sapiens	Inhibition	%	0.81
	8106131	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-1.5	CHEMBL6144	Homo sapiens	Inhibition	%	-1.5
	8106296	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.16	CHEMBL6144	Homo sapiens	Inhibition	%	0.16
	8106452	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	2.35	CHEMBL6144	Homo sapiens	Inhibition	%	2.35
	8106676	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-5.01	CHEMBL6144	Homo sapiens	Inhibition	%	-5.01
	8106805	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.46	CHEMBL6144	Homo sapiens	Inhibition	%	-0.46
	8107150	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.99	CHEMBL6144	Homo sapiens	Inhibition	%	0.99
	8107322	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.71	CHEMBL6144	Homo sapiens	Inhibition	%	3.71
	8107546	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.08	CHEMBL6144	Homo sapiens	Inhibition	%	1.08
	8107747	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	5.33	CHEMBL6144	Homo sapiens	Inhibition	%	5.33
	8107882	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.77	CHEMBL6144	Homo sapiens	Inhibition	%	0.77
	8108264	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	-0.11	CHEMBL6144	Homo sapiens	Inhibition	%	-0.11
	8108439	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.02	CHEMBL6144	Homo sapiens	Inhibition	%	0.02
	8108810	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	9.48	CHEMBL6144	Homo sapiens	Inhibition	%	9.48
	8108952	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.84	CHEMBL6144	Homo sapiens	Inhibition	%	0.84
	8109176	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.78	CHEMBL6144	Homo sapiens	Inhibition	%	0.78
	8109290	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	-0.55	CHEMBL6144	Homo sapiens	Inhibition	%	-0.55
	8109644	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-3.18	CHEMBL6144	Homo sapiens	Inhibition	%	-3.18
	8109815	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	6.21	CHEMBL6144	Homo sapiens	Inhibition	%	6.21
	8110171	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	-0.63	CHEMBL6144	Homo sapiens	Inhibition	%	-0.63
	8110450	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	-0.29	CHEMBL6144	Homo sapiens	Inhibition	%	-0.29
	8110616	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-2.93	CHEMBL6144	Homo sapiens	Inhibition	%	-2.93
	8110998	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	6.23	CHEMBL6144	Homo sapiens	Inhibition	%	6.23
	8111121	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	2.37	CHEMBL6144	Homo sapiens	Inhibition	%	2.37
	8111345	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	2.68	CHEMBL6144	Homo sapiens	Inhibition	%	2.68
	8111472	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-2.91	CHEMBL6144	Homo sapiens	Inhibition	%	-2.91
	8111862	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.67	CHEMBL6144	Homo sapiens	Inhibition	%	0.67
	8112067	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.72	CHEMBL6144	Homo sapiens	Inhibition	%	4.72
	8112204	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.75	CHEMBL6144	Homo sapiens	Inhibition	%	0.75
	8112428	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.13	CHEMBL6144	Homo sapiens	Inhibition	%	1.13
	8112596	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	0.4	CHEMBL6144	Homo sapiens	Inhibition	%	0.4
	8112768	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.69	CHEMBL6144	Homo sapiens	Inhibition	%	0.69
	8112992	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.77	CHEMBL6144	Homo sapiens	Inhibition	%	1.77
	8113144	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	4.94	CHEMBL6144	Homo sapiens	Inhibition	%	4.94
	8113504	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.49	CHEMBL6144	Homo sapiens	Inhibition	%	0.49
	8113628	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.29	CHEMBL6144	Homo sapiens	Inhibition	%	1.29
	8113968	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.59	CHEMBL6144	Homo sapiens	Inhibition	%	0.59
	8114144	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	6.2	CHEMBL6144	Homo sapiens	Inhibition	%	6.2
	8114368	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.84	CHEMBL6144	Homo sapiens	Inhibition	%	3.84
	8114500	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.57	CHEMBL6144	Homo sapiens	Inhibition	%	2.57
	8114776	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	-3.25	CHEMBL6144	Homo sapiens	Inhibition	%	-3.25
	8114942	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	0.64	CHEMBL6144	Homo sapiens	Inhibition	%	0.64
	8115166	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	-4.06	CHEMBL6144	Homo sapiens	Inhibition	%	-4.06
	8115331	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.73	CHEMBL6144	Homo sapiens	Inhibition	%	0.73
	8115675	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.59	CHEMBL6144	Homo sapiens	Inhibition	%	1.59
	8115808	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.91	CHEMBL6144	Homo sapiens	Inhibition	%	0.91
	8116191	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	9.38	CHEMBL6144	Homo sapiens	Inhibition	%	9.38
	8116394	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.09	CHEMBL6144	Homo sapiens	Inhibition	%	4.09
	8116752	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.59	CHEMBL6144	Homo sapiens	Inhibition	%	-0.59
	8116924	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	-0.33	CHEMBL6144	Homo sapiens	Inhibition	%	-0.33
	8117319	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.11	CHEMBL6144	Homo sapiens	Inhibition	%	0.11
	8117477	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.62	CHEMBL6144	Homo sapiens	Inhibition	%	3.62
	8117831	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.68	CHEMBL6144	Homo sapiens	Inhibition	%	0.68
	8117969	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-0.72	CHEMBL6144	Homo sapiens	Inhibition	%	-0.72
	8118193	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.05	CHEMBL6144	Homo sapiens	Inhibition	%	2.05
	8118309	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	4.42	CHEMBL6144	Homo sapiens	Inhibition	%	4.42
	8118705	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	5.11	CHEMBL6144	Homo sapiens	Inhibition	%	5.11
	8118841	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	11.61	CHEMBL6144	Homo sapiens	Inhibition	%	11.61
	8119112	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	12.87	CHEMBL6144	Homo sapiens	Inhibition	%	12.87
	8119495	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	1.52	CHEMBL6144	Homo sapiens	Inhibition	%	1.52
	8119662	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	6.19	CHEMBL6144	Homo sapiens	Inhibition	%	6.19
	8120005	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	3.85	CHEMBL6144	Homo sapiens	Inhibition	%	3.85
	8120144	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.55	CHEMBL6144	Homo sapiens	Inhibition	%	0.55
	8120368	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.19	CHEMBL6144	Homo sapiens	Inhibition	%	2.19
	8120528	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.66	CHEMBL6144	Homo sapiens	Inhibition	%	-0.66
	8120729	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	7.13	CHEMBL6144	Homo sapiens	Inhibition	%	7.13
	8121081	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.78	CHEMBL6144	Homo sapiens	Inhibition	%	-0.78
	8121253	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.99	CHEMBL6144	Homo sapiens	Inhibition	%	-0.99
	8121477	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.46	CHEMBL6144	Homo sapiens	Inhibition	%	1.46
	8121644	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.61	CHEMBL6144	Homo sapiens	Inhibition	%	1.61
	8121807	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.41	CHEMBL6144	Homo sapiens	Inhibition	%	1.41
	8122031	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	3.01	CHEMBL6144	Homo sapiens	Inhibition	%	3.01
	8122152	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.58	CHEMBL6144	Homo sapiens	Inhibition	%	-1.58
	8122514	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	4.87	CHEMBL6144	Homo sapiens	Inhibition	%	4.87
	8122634	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	7.23	CHEMBL6144	Homo sapiens	Inhibition	%	7.23
	8122858	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.64	CHEMBL6144	Homo sapiens	Inhibition	%	3.64
	8123025	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.97	CHEMBL6144	Homo sapiens	Inhibition	%	4.97
	8123167	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	0.88	CHEMBL6144	Homo sapiens	Inhibition	%	0.88
	8123391	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	0.91	CHEMBL6144	Homo sapiens	Inhibition	%	0.91
	8123445	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	51.21	CHEMBL6144	Homo sapiens	Inhibition	%	51.21
	8123669	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.19	CHEMBL6144	Homo sapiens	Inhibition	%	1.19
	8123819	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	-6.34	CHEMBL6144	Homo sapiens	Inhibition	%	-6.34
	8123986	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	2.45	CHEMBL6144	Homo sapiens	Inhibition	%	2.45
	8124210	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	8.28	CHEMBL6144	Homo sapiens	Inhibition	%	8.28
	8124329	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.14	CHEMBL6144	Homo sapiens	Inhibition	%	4.14
	8124692	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-1.83	CHEMBL6144	Homo sapiens	Inhibition	%	-1.83
	8124857	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.38	CHEMBL6144	Homo sapiens	Inhibition	%	2.38
	8125058	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.46	CHEMBL6144	Homo sapiens	Inhibition	%	3.46
	8125282	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.51	CHEMBL6144	Homo sapiens	Inhibition	%	4.51
	8125412	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	3.53	CHEMBL6144	Homo sapiens	Inhibition	%	3.53
	8125804	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-2.66	CHEMBL6144	Homo sapiens	Inhibition	%	-2.66
	8125968	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-2.23	CHEMBL6144	Homo sapiens	Inhibition	%	-2.23
	8126356	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.33	CHEMBL6144	Homo sapiens	Inhibition	%	2.33
	8126471	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.29	CHEMBL6144	Homo sapiens	Inhibition	%	-1.29
	8126831	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	18.69	CHEMBL6144	Homo sapiens	Inhibition	%	18.69
	8127177	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	6.73	CHEMBL6144	Homo sapiens	Inhibition	%	6.73
	8127344	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.17	CHEMBL6144	Homo sapiens	Inhibition	%	4.17
	8127710	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	2.54	CHEMBL6144	Homo sapiens	Inhibition	%	2.54
	8127998	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	-5.44	CHEMBL6144	Homo sapiens	Inhibition	%	-5.44
	8128150	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.76	CHEMBL6144	Homo sapiens	Inhibition	%	3.76
	8128541	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.74	CHEMBL6144	Homo sapiens	Inhibition	%	1.74
	8128660	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	0.06	CHEMBL6144	Homo sapiens	Inhibition	%	0.06
	8128884	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	5.42	CHEMBL6144	Homo sapiens	Inhibition	%	5.42
	8129021	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.24	CHEMBL6144	Homo sapiens	Inhibition	%	0.24
	8129192	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-3.48	CHEMBL6144	Homo sapiens	Inhibition	%	-3.48
	8129416	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.1	CHEMBL6144	Homo sapiens	Inhibition	%	-0.1
	8129605	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.2	CHEMBL6144	Homo sapiens	Inhibition	%	2.2
	8129744	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.48	CHEMBL6144	Homo sapiens	Inhibition	%	0.48
	8129968	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.25	CHEMBL6144	Homo sapiens	Inhibition	%	-0.25
	8130129	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-0.41	CHEMBL6144	Homo sapiens	Inhibition	%	-0.41
	8130301	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.97	CHEMBL6144	Homo sapiens	Inhibition	%	1.97
	8130685	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	1.08	CHEMBL6144	Homo sapiens	Inhibition	%	1.08
	8130801	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.17	CHEMBL6144	Homo sapiens	Inhibition	%	1.17
	8131025	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.47	CHEMBL6144	Homo sapiens	Inhibition	%	2.47
	8131164	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	1.78	CHEMBL6144	Homo sapiens	Inhibition	%	1.78
	8131508	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	4.21	CHEMBL6144	Homo sapiens	Inhibition	%	4.21
	8131675	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.93	CHEMBL6144	Homo sapiens	Inhibition	%	2.93
	8132040	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	0.47	CHEMBL6144	Homo sapiens	Inhibition	%	0.47
	8132326	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	3.68	CHEMBL6144	Homo sapiens	Inhibition	%	3.68
	8132473	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.05	CHEMBL6144	Homo sapiens	Inhibition	%	0.05
	8132697	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	4.25	CHEMBL6144	Homo sapiens	Inhibition	%	4.25
	8132865	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	10.91	CHEMBL6144	Homo sapiens	Inhibition	%	10.91
	8133210	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.78	CHEMBL6144	Homo sapiens	Inhibition	%	1.78
	8133348	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.19	CHEMBL6144	Homo sapiens	Inhibition	%	1.19
	8133744	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.29	CHEMBL6144	Homo sapiens	Inhibition	%	1.29
	8133924	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.86	CHEMBL6144	Homo sapiens	Inhibition	%	1.86
	8134296	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.98	CHEMBL6144	Homo sapiens	Inhibition	%	0.98
	8134456	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.54	CHEMBL6144	Homo sapiens	Inhibition	%	-0.54
	8134640	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-1.94	CHEMBL6144	Homo sapiens	Inhibition	%	-1.94
	8134864	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.5	CHEMBL6144	Homo sapiens	Inhibition	%	0.5
	8135024	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.67	CHEMBL6144	Homo sapiens	Inhibition	%	5.67
	8135363	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	-0.85	CHEMBL6144	Homo sapiens	Inhibition	%	-0.85
	8135504	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.3	CHEMBL6144	Homo sapiens	Inhibition	%	3.3
	8135728	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.23	CHEMBL6144	Homo sapiens	Inhibition	%	3.23
	8135849	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	7.29	CHEMBL6144	Homo sapiens	Inhibition	%	7.29
	8136017	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	5.6	CHEMBL6144	Homo sapiens	Inhibition	%	5.6
	8136241	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	4.38	CHEMBL6144	Homo sapiens	Inhibition	%	4.38
	8136385	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	0.51	CHEMBL6144	Homo sapiens	Inhibition	%	0.51
	8136675	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	17.83	CHEMBL6144	Homo sapiens	Inhibition	%	17.83
	8137034	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	7.35	CHEMBL6144	Homo sapiens	Inhibition	%	7.35
	8137197	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	3.49	CHEMBL6144	Homo sapiens	Inhibition	%	3.49
	8137541	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	4.6	CHEMBL6144	Homo sapiens	Inhibition	%	4.6
	8137689	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.16	CHEMBL6144	Homo sapiens	Inhibition	%	2.16
	8137913	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-1.91	CHEMBL6144	Homo sapiens	Inhibition	%	-1.91
	8138079	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	2.2	CHEMBL6144	Homo sapiens	Inhibition	%	2.2
	8138258	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.43	CHEMBL6144	Homo sapiens	Inhibition	%	0.43
	8138630	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-3.15	CHEMBL6144	Homo sapiens	Inhibition	%	-3.15
	8138788	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.27	CHEMBL6144	Homo sapiens	Inhibition	%	1.27
	8139012	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.63	CHEMBL6144	Homo sapiens	Inhibition	%	0.63
	8139197	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.84	CHEMBL6144	Homo sapiens	Inhibition	%	4.84
	8139356	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.26	CHEMBL6144	Homo sapiens	Inhibition	%	1.26
	8139694	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.09	CHEMBL6144	Homo sapiens	Inhibition	%	1.09
	8140059	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.79	CHEMBL6144	Homo sapiens	Inhibition	%	4.79
	8140182	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.68	CHEMBL6144	Homo sapiens	Inhibition	%	3.68
	8140565	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.55	CHEMBL6144	Homo sapiens	Inhibition	%	1.55
	8140708	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.27	CHEMBL6144	Homo sapiens	Inhibition	%	2.27
	8140932	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	1.68	CHEMBL6144	Homo sapiens	Inhibition	%	1.68
	8141010	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.54	CHEMBL6144	Homo sapiens	Inhibition	%	1.54
	8141364	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.97	CHEMBL6144	Homo sapiens	Inhibition	%	1.97
	8141524	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	3.97	CHEMBL6144	Homo sapiens	Inhibition	%	3.97
	8141748	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	3.24	CHEMBL6144	Homo sapiens	Inhibition	%	3.24
	8141867	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.29	CHEMBL6144	Homo sapiens	Inhibition	%	-0.29
	8142252	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-1.49	CHEMBL6144	Homo sapiens	Inhibition	%	-1.49
	8142420	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.55	CHEMBL6144	Homo sapiens	Inhibition	%	-1.55
	8142596	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.06	CHEMBL6144	Homo sapiens	Inhibition	%	0.06
	8142820	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.32	CHEMBL6144	Homo sapiens	Inhibition	%	0.32
	8142969	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.12	CHEMBL6144	Homo sapiens	Inhibition	%	-2.12
	8143348	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.83	CHEMBL6144	Homo sapiens	Inhibition	%	0.83
	8143535	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	17.75	CHEMBL6144	Homo sapiens	Inhibition	%	17.75
	8143694	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	2.15	CHEMBL6144	Homo sapiens	Inhibition	%	2.15
	8143918	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	2.48	CHEMBL6144	Homo sapiens	Inhibition	%	2.48
	8144032	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-2.27	CHEMBL6144	Homo sapiens	Inhibition	%	-2.27
	8144395	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.23	CHEMBL6144	Homo sapiens	Inhibition	%	2.23
	8144525	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.13	CHEMBL6144	Homo sapiens	Inhibition	%	4.13
	8144749	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.21	CHEMBL6144	Homo sapiens	Inhibition	%	4.21
	8144902	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.77	CHEMBL6144	Homo sapiens	Inhibition	%	2.77
	8145263	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	1.4	CHEMBL6144	Homo sapiens	Inhibition	%	1.4
	8145352	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	-3.01	CHEMBL6144	Homo sapiens	Inhibition	%	-3.01
	8145576	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.38	CHEMBL6144	Homo sapiens	Inhibition	%	2.38
	8145700	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-2.2	CHEMBL6144	Homo sapiens	Inhibition	%	-2.2
	8146085	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	3.8	CHEMBL6144	Homo sapiens	Inhibition	%	3.8
	8146205	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	2.62	CHEMBL6144	Homo sapiens	Inhibition	%	2.62
	8146589	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	27.52	CHEMBL6144	Homo sapiens	Inhibition	%	27.52
	8146756	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.03	CHEMBL6144	Homo sapiens	Inhibition	%	-1.03
	8147149	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	5.9	CHEMBL6144	Homo sapiens	Inhibition	%	5.9
	8147291	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-2.23	CHEMBL6144	Homo sapiens	Inhibition	%	-2.23
	8147668	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	3.32	CHEMBL6144	Homo sapiens	Inhibition	%	3.32
	8147855	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	7.82	CHEMBL6144	Homo sapiens	Inhibition	%	7.82
	8148237	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.61	CHEMBL6144	Homo sapiens	Inhibition	%	4.61
	8148351	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.12	CHEMBL6144	Homo sapiens	Inhibition	%	2.12
	8148575	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-0.58	CHEMBL6144	Homo sapiens	Inhibition	%	-0.58
	8148714	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.45	CHEMBL6144	Homo sapiens	Inhibition	%	4.45
	8149076	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	7.44	CHEMBL6144	Homo sapiens	Inhibition	%	7.44
	8149235	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.99	CHEMBL6144	Homo sapiens	Inhibition	%	0.99
	8149593	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	-0.59	CHEMBL6144	Homo sapiens	Inhibition	%	-0.59
	8149915	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	-2.05	CHEMBL6144	Homo sapiens	Inhibition	%	-2.05
	8150040	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.72	CHEMBL6144	Homo sapiens	Inhibition	%	0.72
	8150424	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.71	CHEMBL6144	Homo sapiens	Inhibition	%	0.71
	8150544	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.1	CHEMBL6144	Homo sapiens	Inhibition	%	-0.1
	8150768	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	4.85	CHEMBL6144	Homo sapiens	Inhibition	%	4.85
	8150933	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	82.8	CHEMBL6144	Homo sapiens	Inhibition	%	82.8
	8151096	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	1.1	CHEMBL6144	Homo sapiens	Inhibition	%	1.1
	8151320	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.57	CHEMBL6144	Homo sapiens	Inhibition	%	-1.57
	8151497	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.01	CHEMBL6144	Homo sapiens	Inhibition	%	3.01
	8151635	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-0.87	CHEMBL6144	Homo sapiens	Inhibition	%	-0.87
	8151859	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-2.91	CHEMBL6144	Homo sapiens	Inhibition	%	-2.91
	8152013	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.16	CHEMBL6144	Homo sapiens	Inhibition	%	2.16
	8152201	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	43.48	CHEMBL6144	Homo sapiens	Inhibition	%	43.48
	8152425	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.3	CHEMBL6144	Homo sapiens	Inhibition	%	3.3
	8152583	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.8	CHEMBL6144	Homo sapiens	Inhibition	%	4.8
	8152921	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	1.67	CHEMBL6144	Homo sapiens	Inhibition	%	1.67
	8153060	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-0.68	CHEMBL6144	Homo sapiens	Inhibition	%	-0.68
	8153421	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	6.32	CHEMBL6144	Homo sapiens	Inhibition	%	6.32
	8153578	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	3.25	CHEMBL6144	Homo sapiens	Inhibition	%	3.25
	8153802	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.1	CHEMBL6144	Homo sapiens	Inhibition	%	1.1
	8153935	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.57	CHEMBL6144	Homo sapiens	Inhibition	%	5.57
	8154256	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.21	CHEMBL6144	Homo sapiens	Inhibition	%	1.21
	8154382	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-4.1	CHEMBL6144	Homo sapiens	Inhibition	%	-4.1
	8154606	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.2	CHEMBL6144	Homo sapiens	Inhibition	%	1.2
	8154765	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	3.57	CHEMBL6144	Homo sapiens	Inhibition	%	3.57
	8155109	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-2.41	CHEMBL6144	Homo sapiens	Inhibition	%	-2.41
	8155285	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.46	CHEMBL6144	Homo sapiens	Inhibition	%	-1.46
	8155670	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	7.5	CHEMBL6144	Homo sapiens	Inhibition	%	7.5
	8155848	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	4.64	CHEMBL6144	Homo sapiens	Inhibition	%	4.64
	8156210	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-2.59	CHEMBL6144	Homo sapiens	Inhibition	%	-2.59
	8156422	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.77	CHEMBL6144	Homo sapiens	Inhibition	%	3.77
	8156796	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	4.41	CHEMBL6144	Homo sapiens	Inhibition	%	4.41
	8156939	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.06	CHEMBL6144	Homo sapiens	Inhibition	%	3.06
	8157283	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	14.7	CHEMBL6144	Homo sapiens	Inhibition	%	14.7
	8157424	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	1.33	CHEMBL6144	Homo sapiens	Inhibition	%	1.33
	8157648	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	4.77	CHEMBL6144	Homo sapiens	Inhibition	%	4.77
	8157778	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	4.81	CHEMBL6144	Homo sapiens	Inhibition	%	4.81
	8158163	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.32	CHEMBL6144	Homo sapiens	Inhibition	%	0.32
	8158413	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	6.84	CHEMBL6144	Homo sapiens	Inhibition	%	6.84
	8158571	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	0.85	CHEMBL6144	Homo sapiens	Inhibition	%	0.85
	8158964	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.76	CHEMBL6144	Homo sapiens	Inhibition	%	3.76
	8159099	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	9.5	CHEMBL6144	Homo sapiens	Inhibition	%	9.5
	8159323	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	13.63	CHEMBL6144	Homo sapiens	Inhibition	%	13.63
	8159443	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	5.32	CHEMBL6144	Homo sapiens	Inhibition	%	5.32
	8159798	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	5.66	CHEMBL6144	Homo sapiens	Inhibition	%	5.66
	8159939	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.38	CHEMBL6144	Homo sapiens	Inhibition	%	2.38
	8160300	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.14	CHEMBL6144	Homo sapiens	Inhibition	%	4.14
	8160450	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.78	CHEMBL6144	Homo sapiens	Inhibition	%	1.78
	8160744	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	-1.16	CHEMBL6144	Homo sapiens	Inhibition	%	-1.16
	8161118	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	7.67	CHEMBL6144	Homo sapiens	Inhibition	%	7.67
	8161261	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	7.21	CHEMBL6144	Homo sapiens	Inhibition	%	7.21
	8161485	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	4.01	CHEMBL6144	Homo sapiens	Inhibition	%	4.01
	8161610	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.82	CHEMBL6144	Homo sapiens	Inhibition	%	1.82
	8161972	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.03	CHEMBL6144	Homo sapiens	Inhibition	%	4.03
	8162102	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	6.4	CHEMBL6144	Homo sapiens	Inhibition	%	6.4
	8162326	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	6.53	CHEMBL6144	Homo sapiens	Inhibition	%	6.53
	8162486	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-5.54	CHEMBL6144	Homo sapiens	Inhibition	%	-5.54
	8162739	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	8.03	CHEMBL6144	Homo sapiens	Inhibition	%	8.03
	8162887	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	6.28	CHEMBL6144	Homo sapiens	Inhibition	%	6.28
	8163111	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	35.54	CHEMBL6144	Homo sapiens	Inhibition	%	35.54
	8163280	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.58	CHEMBL6144	Homo sapiens	Inhibition	%	3.58
	8163638	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	9.58	CHEMBL6144	Homo sapiens	Inhibition	%	9.58
	8163761	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	4.18	CHEMBL6144	Homo sapiens	Inhibition	%	4.18
	8164119	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	25.3	CHEMBL6144	Homo sapiens	Inhibition	%	25.3
	8164259	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.95	CHEMBL6144	Homo sapiens	Inhibition	%	0.95
	8164483	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	2.33	CHEMBL6144	Homo sapiens	Inhibition	%	2.33
	8164638	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	2.91	CHEMBL6144	Homo sapiens	Inhibition	%	2.91
	8164782	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-1.92	CHEMBL6144	Homo sapiens	Inhibition	%	-1.92
	8165006	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.24	CHEMBL6144	Homo sapiens	Inhibition	%	2.24
	8165076	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	14.48	CHEMBL6144	Homo sapiens	Inhibition	%	14.48
	8165300	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	56.66	CHEMBL6144	Homo sapiens	Inhibition	%	56.66
	8165441	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	5.36	CHEMBL6144	Homo sapiens	Inhibition	%	5.36
	8165808	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	-2.78	CHEMBL6144	Homo sapiens	Inhibition	%	-2.78
	8165934	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.13	CHEMBL6144	Homo sapiens	Inhibition	%	2.13
	8166296	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	8.09	CHEMBL6144	Homo sapiens	Inhibition	%	8.09
	8166650	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	4.9	CHEMBL6144	Homo sapiens	Inhibition	%	4.9
	8166751	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	-4.13	CHEMBL6144	Homo sapiens	Inhibition	%	-4.13
	8167063	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	6.32	CHEMBL6144	Homo sapiens	Inhibition	%	6.32
	8167428	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	49.46	CHEMBL6144	Homo sapiens	Inhibition	%	49.46
	8167592	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.47	CHEMBL6144	Homo sapiens	Inhibition	%	3.47
	8167949	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	11.26	CHEMBL6144	Homo sapiens	Inhibition	%	11.26
	8168073	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	5.16	CHEMBL6144	Homo sapiens	Inhibition	%	5.16
	8168297	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	7.3	CHEMBL6144	Homo sapiens	Inhibition	%	7.3
	8168438	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	0.86	CHEMBL6144	Homo sapiens	Inhibition	%	0.86
	8168798	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.43	CHEMBL6144	Homo sapiens	Inhibition	%	1.43
	8168962	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	8.01	CHEMBL6144	Homo sapiens	Inhibition	%	8.01
	8169328	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.55	CHEMBL6144	Homo sapiens	Inhibition	%	1.55
	8169632	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	5.89	CHEMBL6144	Homo sapiens	Inhibition	%	5.89
	8169766	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	12.04	CHEMBL6144	Homo sapiens	Inhibition	%	12.04
	8170135	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	-6.02	CHEMBL6144	Homo sapiens	Inhibition	%	-6.02
	8170260	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.1	CHEMBL6144	Homo sapiens	Inhibition	%	2.1
	8170484	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.62	CHEMBL6144	Homo sapiens	Inhibition	%	3.62
	8170624	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	4.53	CHEMBL6144	Homo sapiens	Inhibition	%	4.53
	8170983	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	4.74	CHEMBL6144	Homo sapiens	Inhibition	%	4.74
	8171180	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	-0.47	CHEMBL6144	Homo sapiens	Inhibition	%	-0.47
	8171397	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	9.42	CHEMBL6144	Homo sapiens	Inhibition	%	9.42
	8171762	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	87.15	CHEMBL6144	Homo sapiens	Inhibition	%	87.15
	8171915	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	3.44	CHEMBL6144	Homo sapiens	Inhibition	%	3.44
	8172139	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.12	CHEMBL6144	Homo sapiens	Inhibition	%	0.12
	8172271	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	8.17	CHEMBL6144	Homo sapiens	Inhibition	%	8.17
	8172623	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.73	CHEMBL6144	Homo sapiens	Inhibition	%	1.73
	8172765	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.38	CHEMBL6144	Homo sapiens	Inhibition	%	2.38
	8173125	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	2.82	CHEMBL6144	Homo sapiens	Inhibition	%	2.82
	8173290	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	1.7	CHEMBL6144	Homo sapiens	Inhibition	%	1.7
	8173514	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	1.85	CHEMBL6144	Homo sapiens	Inhibition	%	1.85
	8173655	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	11.35	CHEMBL6144	Homo sapiens	Inhibition	%	11.35
	8173966	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	9.39	CHEMBL6144	Homo sapiens	Inhibition	%	9.39
	8174098	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	7.47	CHEMBL6144	Homo sapiens	Inhibition	%	7.47
	8174322	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	9.38	CHEMBL6144	Homo sapiens	Inhibition	%	9.38
	8174470	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.72	CHEMBL6144	Homo sapiens	Inhibition	%	1.72
	8174816	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.11	CHEMBL6144	Homo sapiens	Inhibition	%	2.11
	8174959	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	11.05	CHEMBL6144	Homo sapiens	Inhibition	%	11.05
	8175183	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	5.6	CHEMBL6144	Homo sapiens	Inhibition	%	5.6
	8175319	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	3.14	CHEMBL6144	Homo sapiens	Inhibition	%	3.14
	8175575	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	14.77	CHEMBL6144	Homo sapiens	Inhibition	%	14.77
	8175738	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.92	CHEMBL6144	Homo sapiens	Inhibition	%	3.92
	8175962	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.28	CHEMBL6144	Homo sapiens	Inhibition	%	3.28
	8176115	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	5.51	CHEMBL6144	Homo sapiens	Inhibition	%	5.51
	8176488	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	3.15	CHEMBL6144	Homo sapiens	Inhibition	%	3.15
	8176620	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	23.66	CHEMBL6144	Homo sapiens	Inhibition	%	23.66
	8176974	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	4.13	CHEMBL6144	Homo sapiens	Inhibition	%	4.13
	8177116	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.06	CHEMBL6144	Homo sapiens	Inhibition	%	1.06
	8177340	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	5.14	CHEMBL6144	Homo sapiens	Inhibition	%	5.14
	8177478	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	20.2	CHEMBL6144	Homo sapiens	Inhibition	%	20.2
	8177866	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	5.89	CHEMBL6144	Homo sapiens	Inhibition	%	5.89
	8178006	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	46.13	CHEMBL6144	Homo sapiens	Inhibition	%	46.13
	8178318	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	3.73	CHEMBL6144	Homo sapiens	Inhibition	%	3.73
	8178669	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	5.53	CHEMBL6144	Homo sapiens	Inhibition	%	5.53
	8178818	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-2.28	CHEMBL6144	Homo sapiens	Inhibition	%	-2.28
	8179165	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.14	CHEMBL6144	Homo sapiens	Inhibition	%	4.14
	8179533	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	21.9	CHEMBL6144	Homo sapiens	Inhibition	%	21.9
	8179670	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	5.12	CHEMBL6144	Homo sapiens	Inhibition	%	5.12
	8179927	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	7.16	CHEMBL6144	Homo sapiens	Inhibition	%	7.16
	8180305	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	5.0	CHEMBL6144	Homo sapiens	Inhibition	%	5.0
	8180461	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	7.31	CHEMBL6144	Homo sapiens	Inhibition	%	7.31
	8180833	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	5.15	CHEMBL6144	Homo sapiens	Inhibition	%	5.15
	8180966	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	6.06	CHEMBL6144	Homo sapiens	Inhibition	%	6.06
	8181190	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	7.8	CHEMBL6144	Homo sapiens	Inhibition	%	7.8
	8181321	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.76	CHEMBL6144	Homo sapiens	Inhibition	%	-0.76
	8181685	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.59	CHEMBL6144	Homo sapiens	Inhibition	%	2.59
	8181824	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	41.23	CHEMBL6144	Homo sapiens	Inhibition	%	41.23
	8182048	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.85	CHEMBL6144	Homo sapiens	Inhibition	%	7.85
	8182211	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	5.57	CHEMBL6144	Homo sapiens	Inhibition	%	5.57
	8182351	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.33	CHEMBL6144	Homo sapiens	Inhibition	%	0.33
	8182575	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-0.08	CHEMBL6144	Homo sapiens	Inhibition	%	-0.08
	8182667	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.78	CHEMBL6144	Homo sapiens	Inhibition	%	0.78
	8183013	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	7.7	CHEMBL6144	Homo sapiens	Inhibition	%	7.7
	8183162	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	-1.06	CHEMBL6144	Homo sapiens	Inhibition	%	-1.06
	8183386	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	-5.0	CHEMBL6144	Homo sapiens	Inhibition	%	-5.0
	8183515	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.14	CHEMBL6144	Homo sapiens	Inhibition	%	1.14
	8183881	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	4.41	CHEMBL6144	Homo sapiens	Inhibition	%	4.41
	8184017	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.91	CHEMBL6144	Homo sapiens	Inhibition	%	1.91
	8184241	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.17	CHEMBL6144	Homo sapiens	Inhibition	%	1.17
	8184283	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	14.5	CHEMBL6144	Homo sapiens	Inhibition	%	14.5
	8184507	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	8.35	CHEMBL6144	Homo sapiens	Inhibition	%	8.35
	8184654	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.64	CHEMBL6144	Homo sapiens	Inhibition	%	2.64
	8184811	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	2.14	CHEMBL6144	Homo sapiens	Inhibition	%	2.14
	8185035	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.87	CHEMBL6144	Homo sapiens	Inhibition	%	1.87
	8185184	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.84	CHEMBL6144	Homo sapiens	Inhibition	%	1.84
	8185539	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	7.52	CHEMBL6144	Homo sapiens	Inhibition	%	7.52
	8185670	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	9.44	CHEMBL6144	Homo sapiens	Inhibition	%	9.44
	8185894	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	5.35	CHEMBL6144	Homo sapiens	Inhibition	%	5.35
	8186033	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.48	CHEMBL6144	Homo sapiens	Inhibition	%	3.48
	8186398	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	10.11	CHEMBL6144	Homo sapiens	Inhibition	%	10.11
	8186562	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	8.72	CHEMBL6144	Homo sapiens	Inhibition	%	8.72
	8186925	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.73	CHEMBL6144	Homo sapiens	Inhibition	%	2.73
	8187023	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.81	CHEMBL6144	Homo sapiens	Inhibition	%	2.81
	8187247	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.48	CHEMBL6144	Homo sapiens	Inhibition	%	0.48
	8187371	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	4.64	CHEMBL6144	Homo sapiens	Inhibition	%	4.64
	8187743	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	-2.11	CHEMBL6144	Homo sapiens	Inhibition	%	-2.11
	8187872	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	12.56	CHEMBL6144	Homo sapiens	Inhibition	%	12.56
	8188096	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	6.21	CHEMBL6144	Homo sapiens	Inhibition	%	6.21
	8188239	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	8.19	CHEMBL6144	Homo sapiens	Inhibition	%	8.19
	8188598	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-1.78	CHEMBL6144	Homo sapiens	Inhibition	%	-1.78
	8188872	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	9.33	CHEMBL6144	Homo sapiens	Inhibition	%	9.33
	8189020	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	4.24	CHEMBL6144	Homo sapiens	Inhibition	%	4.24
	8189400	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.98	CHEMBL6144	Homo sapiens	Inhibition	%	3.98
	8189549	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	3.06	CHEMBL6144	Homo sapiens	Inhibition	%	3.06
	8189773	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.48	CHEMBL6144	Homo sapiens	Inhibition	%	0.48
	8189905	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	6.6	CHEMBL6144	Homo sapiens	Inhibition	%	6.6
	8190261	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	30.3	CHEMBL6144	Homo sapiens	Inhibition	%	30.3
	8190401	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.52	CHEMBL6144	Homo sapiens	Inhibition	%	3.52
	8190762	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.71	CHEMBL6144	Homo sapiens	Inhibition	%	4.71
	8190926	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	8.49	CHEMBL6144	Homo sapiens	Inhibition	%	8.49
	8191150	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	29.71	CHEMBL6144	Homo sapiens	Inhibition	%	29.71
	8191288	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	-0.52	CHEMBL6144	Homo sapiens	Inhibition	%	-0.52
	8191608	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.1	CHEMBL6144	Homo sapiens	Inhibition	%	3.1
	8191730	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.84	CHEMBL6144	Homo sapiens	Inhibition	%	5.84
	8191954	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	3.39	CHEMBL6144	Homo sapiens	Inhibition	%	3.39
	8192103	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	-0.96	CHEMBL6144	Homo sapiens	Inhibition	%	-0.96
	8192456	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	16.41	CHEMBL6144	Homo sapiens	Inhibition	%	16.41
	8192600	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.92	CHEMBL6144	Homo sapiens	Inhibition	%	3.92
	8192960	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.38	CHEMBL6144	Homo sapiens	Inhibition	%	2.38
	8193232	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.99	CHEMBL6144	Homo sapiens	Inhibition	%	5.99
	8193377	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	77.56	CHEMBL6144	Homo sapiens	Inhibition	%	77.56
	8193601	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.37	CHEMBL6144	Homo sapiens	Inhibition	%	2.37
	8193758	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	11.51	CHEMBL6144	Homo sapiens	Inhibition	%	11.51
	8194131	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	2.71	CHEMBL6144	Homo sapiens	Inhibition	%	2.71
	8194262	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	6.0	CHEMBL6144	Homo sapiens	Inhibition	%	6.0
	8194617	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	0.71	CHEMBL6144	Homo sapiens	Inhibition	%	0.71
	8194760	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.56	CHEMBL6144	Homo sapiens	Inhibition	%	3.56
	8194984	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.98	CHEMBL6144	Homo sapiens	Inhibition	%	2.98
	8195117	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	6.12	CHEMBL6144	Homo sapiens	Inhibition	%	6.12
	8195505	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	79.58	CHEMBL6144	Homo sapiens	Inhibition	%	79.58
	8195644	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	0.03	CHEMBL6144	Homo sapiens	Inhibition	%	0.03
	8195966	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	-2.54	CHEMBL6144	Homo sapiens	Inhibition	%	-2.54
	8196307	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	3.05	CHEMBL6144	Homo sapiens	Inhibition	%	3.05
	8196457	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	0.38	CHEMBL6144	Homo sapiens	Inhibition	%	0.38
	8196809	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	4.35	CHEMBL6144	Homo sapiens	Inhibition	%	4.35
	8196950	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	8.41	CHEMBL6144	Homo sapiens	Inhibition	%	8.41
	8197174	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.02	CHEMBL6144	Homo sapiens	Inhibition	%	2.02
	8197311	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.28	CHEMBL6144	Homo sapiens	Inhibition	%	0.28
	8197586	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	6.88	CHEMBL6144	Homo sapiens	Inhibition	%	6.88
	8197950	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	5.7	CHEMBL6144	Homo sapiens	Inhibition	%	5.7
	8198107	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.79	CHEMBL6144	Homo sapiens	Inhibition	%	2.79
	8198469	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	7.85	CHEMBL6144	Homo sapiens	Inhibition	%	7.85
	8198599	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	5.91	CHEMBL6144	Homo sapiens	Inhibition	%	5.91
	8198823	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	6.74	CHEMBL6144	Homo sapiens	Inhibition	%	6.74
	8198954	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.31	CHEMBL6144	Homo sapiens	Inhibition	%	3.31
	8199326	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	6.85	CHEMBL6144	Homo sapiens	Inhibition	%	6.85
	8199460	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	7.01	CHEMBL6144	Homo sapiens	Inhibition	%	7.01
	8199847	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.27	CHEMBL6144	Homo sapiens	Inhibition	%	2.27
	8199985	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.18	CHEMBL6144	Homo sapiens	Inhibition	%	1.18
	8200209	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	1.43	CHEMBL6144	Homo sapiens	Inhibition	%	1.43
	8200313	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	2.85	CHEMBL6144	Homo sapiens	Inhibition	%	2.85
	8200652	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	4.89	CHEMBL6144	Homo sapiens	Inhibition	%	4.89
	8200802	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	-3.54	CHEMBL6144	Homo sapiens	Inhibition	%	-3.54
	8201026	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	0.85	CHEMBL6144	Homo sapiens	Inhibition	%	0.85
	8201156	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	17.93	CHEMBL6144	Homo sapiens	Inhibition	%	17.93
	8201515	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	8.2	CHEMBL6144	Homo sapiens	Inhibition	%	8.2
	8201648	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	2.06	CHEMBL6144	Homo sapiens	Inhibition	%	2.06
	8201872	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.69	CHEMBL6144	Homo sapiens	Inhibition	%	-0.69
	8201927	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	9.26	CHEMBL6144	Homo sapiens	Inhibition	%	9.26
	8202151	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	5.4	CHEMBL6144	Homo sapiens	Inhibition	%	5.4
	8202291	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.91	CHEMBL6144	Homo sapiens	Inhibition	%	0.91
	8202458	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-0.16	CHEMBL6144	Homo sapiens	Inhibition	%	-0.16
	8202682	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.78	CHEMBL6144	Homo sapiens	Inhibition	%	3.78
	8202807	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	15.74	CHEMBL6144	Homo sapiens	Inhibition	%	15.74
	8203161	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	8.58	CHEMBL6144	Homo sapiens	Inhibition	%	8.58
	8203292	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-0.96	CHEMBL6144	Homo sapiens	Inhibition	%	-0.96
	8203662	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	4.92	CHEMBL6144	Homo sapiens	Inhibition	%	4.92
	8203796	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	9.97	CHEMBL6144	Homo sapiens	Inhibition	%	9.97
	8204020	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	8.13	CHEMBL6144	Homo sapiens	Inhibition	%	8.13
	8204186	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.46	CHEMBL6144	Homo sapiens	Inhibition	%	2.46
	8204547	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	-3.7	CHEMBL6144	Homo sapiens	Inhibition	%	-3.7
	8204652	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.72	CHEMBL6144	Homo sapiens	Inhibition	%	1.72
	8204876	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.94	CHEMBL6144	Homo sapiens	Inhibition	%	1.94
	8204991	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	5.42	CHEMBL6144	Homo sapiens	Inhibition	%	5.42
	8205364	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.72	CHEMBL6144	Homo sapiens	Inhibition	%	1.72
	8205500	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	4.85	CHEMBL6144	Homo sapiens	Inhibition	%	4.85
	8205724	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	18.11	CHEMBL6144	Homo sapiens	Inhibition	%	18.11
	8205863	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.05	CHEMBL6144	Homo sapiens	Inhibition	%	2.05
	8206219	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.66	CHEMBL6144	Homo sapiens	Inhibition	%	-0.66
	8206495	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	5.17	CHEMBL6144	Homo sapiens	Inhibition	%	5.17
	8206638	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	10.66	CHEMBL6144	Homo sapiens	Inhibition	%	10.66
	8207042	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.55	CHEMBL6144	Homo sapiens	Inhibition	%	3.55
	8207168	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	10.41	CHEMBL6144	Homo sapiens	Inhibition	%	10.41
	8207522	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	11.56	CHEMBL6144	Homo sapiens	Inhibition	%	11.56
	8207654	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	1.02	CHEMBL6144	Homo sapiens	Inhibition	%	1.02
	8207878	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	0.24	CHEMBL6144	Homo sapiens	Inhibition	%	0.24
	8208023	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.86	CHEMBL6144	Homo sapiens	Inhibition	%	3.86
	8208379	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	8.91	CHEMBL6144	Homo sapiens	Inhibition	%	8.91
	8208545	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.91	CHEMBL6144	Homo sapiens	Inhibition	%	2.91
	8208902	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.65	CHEMBL6144	Homo sapiens	Inhibition	%	0.65
	8209231	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.56	CHEMBL6144	Homo sapiens	Inhibition	%	-0.56
	8209347	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	5.73	CHEMBL6144	Homo sapiens	Inhibition	%	5.73
	8209571	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.87	CHEMBL6144	Homo sapiens	Inhibition	%	1.87
	8209721	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.33	CHEMBL6144	Homo sapiens	Inhibition	%	0.33
	8210081	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	3.78	CHEMBL6144	Homo sapiens	Inhibition	%	3.78
	8210222	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	6.65	CHEMBL6144	Homo sapiens	Inhibition	%	6.65
	8210582	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.54	CHEMBL6144	Homo sapiens	Inhibition	%	-2.54
	8210841	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	5.38	CHEMBL6144	Homo sapiens	Inhibition	%	5.38
	8210985	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	-0.86	CHEMBL6144	Homo sapiens	Inhibition	%	-0.86
	8211209	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.16	CHEMBL6144	Homo sapiens	Inhibition	%	1.16
	8211379	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.43	CHEMBL6144	Homo sapiens	Inhibition	%	3.43
	8211502	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	15.36	CHEMBL6144	Homo sapiens	Inhibition	%	15.36
	8211726	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	9.59	CHEMBL6144	Homo sapiens	Inhibition	%	9.59
	8211855	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	32.61	CHEMBL6144	Homo sapiens	Inhibition	%	32.61
	8212211	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.95	CHEMBL6144	Homo sapiens	Inhibition	%	2.95
	8212352	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.59	CHEMBL6144	Homo sapiens	Inhibition	%	1.59
	8212576	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.04	CHEMBL6144	Homo sapiens	Inhibition	%	1.04
	8212709	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.35	CHEMBL6144	Homo sapiens	Inhibition	%	3.35
	8212879	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	13.47	CHEMBL6144	Homo sapiens	Inhibition	%	13.47
	8213103	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.54	CHEMBL6144	Homo sapiens	Inhibition	%	2.54
	8213232	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	6.46	CHEMBL6144	Homo sapiens	Inhibition	%	6.46
	8213560	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	2.37	CHEMBL6144	Homo sapiens	Inhibition	%	2.37
	8213897	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.13	CHEMBL6144	Homo sapiens	Inhibition	%	3.13
	8214044	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	-2.37	CHEMBL6144	Homo sapiens	Inhibition	%	-2.37
	8214405	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	15.03	CHEMBL6144	Homo sapiens	Inhibition	%	15.03
	8214539	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	1.49	CHEMBL6144	Homo sapiens	Inhibition	%	1.49
	8214763	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	6.26	CHEMBL6144	Homo sapiens	Inhibition	%	6.26
	8214915	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-5.07	CHEMBL6144	Homo sapiens	Inhibition	%	-5.07
	8215166	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.54	CHEMBL6144	Homo sapiens	Inhibition	%	4.54
	8215543	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.34	CHEMBL6144	Homo sapiens	Inhibition	%	1.34
	8215707	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	5.16	CHEMBL6144	Homo sapiens	Inhibition	%	5.16
	8216050	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	12.98	CHEMBL6144	Homo sapiens	Inhibition	%	12.98
	8216169	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.91	CHEMBL6144	Homo sapiens	Inhibition	%	5.91
	8216393	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	9.67	CHEMBL6144	Homo sapiens	Inhibition	%	9.67
	8216529	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.32	CHEMBL6144	Homo sapiens	Inhibition	%	2.32
	8216891	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.64	CHEMBL6144	Homo sapiens	Inhibition	%	3.64
	8217025	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	10.42	CHEMBL6144	Homo sapiens	Inhibition	%	10.42
	8217423	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.81	CHEMBL6144	Homo sapiens	Inhibition	%	0.81
	8217554	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	13.85	CHEMBL6144	Homo sapiens	Inhibition	%	13.85
	8217778	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.6	CHEMBL6144	Homo sapiens	Inhibition	%	3.6
	8217879	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.84	CHEMBL6144	Homo sapiens	Inhibition	%	-0.84
	8218218	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.76	CHEMBL6144	Homo sapiens	Inhibition	%	2.76
	8218345	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	-2.74	CHEMBL6144	Homo sapiens	Inhibition	%	-2.74
	8218569	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	-7.47	CHEMBL6144	Homo sapiens	Inhibition	%	-7.47
	8218712	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	4.19	CHEMBL6144	Homo sapiens	Inhibition	%	4.19
	8219067	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.58	CHEMBL6144	Homo sapiens	Inhibition	%	2.58
	8219227	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-7.11	CHEMBL6144	Homo sapiens	Inhibition	%	-7.11
	8219477	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	5.62	CHEMBL6144	Homo sapiens	Inhibition	%	5.62
	8219862	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.56	CHEMBL6144	Homo sapiens	Inhibition	%	1.56
	8220031	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.35	CHEMBL6144	Homo sapiens	Inhibition	%	4.35
	8220384	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	6.97	CHEMBL6144	Homo sapiens	Inhibition	%	6.97
	8220722	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.52	CHEMBL6144	Homo sapiens	Inhibition	%	4.52
	8220860	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	14.99	CHEMBL6144	Homo sapiens	Inhibition	%	14.99
	8221220	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	11.59	CHEMBL6144	Homo sapiens	Inhibition	%	11.59
	8221353	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	6.59	CHEMBL6144	Homo sapiens	Inhibition	%	6.59
	8221577	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	10.77	CHEMBL6144	Homo sapiens	Inhibition	%	10.77
	8221742	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.54	CHEMBL6144	Homo sapiens	Inhibition	%	1.54
	8222097	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.35	CHEMBL6144	Homo sapiens	Inhibition	%	1.35
	8222195	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.78	CHEMBL6144	Homo sapiens	Inhibition	%	3.78
	8222419	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	10.8	CHEMBL6144	Homo sapiens	Inhibition	%	10.8
	8222553	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.73	CHEMBL6144	Homo sapiens	Inhibition	%	4.73
	8222895	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.68	CHEMBL6144	Homo sapiens	Inhibition	%	3.68
	8223039	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	12.72	CHEMBL6144	Homo sapiens	Inhibition	%	12.72
	8223392	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	4.7	CHEMBL6144	Homo sapiens	Inhibition	%	4.7
	8223553	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-3.0	CHEMBL6144	Homo sapiens	Inhibition	%	-3.0
	8223777	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-5.27	CHEMBL6144	Homo sapiens	Inhibition	%	-5.27
	8223803	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	5.87	CHEMBL6144	Homo sapiens	Inhibition	%	5.87
	8224027	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	8.14	CHEMBL6144	Homo sapiens	Inhibition	%	8.14
	8224189	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.49	CHEMBL6144	Homo sapiens	Inhibition	%	2.49
	8224359	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.09	CHEMBL6144	Homo sapiens	Inhibition	%	5.09
	8224583	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.61	CHEMBL6144	Homo sapiens	Inhibition	%	2.61
	8224718	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	11.12	CHEMBL6144	Homo sapiens	Inhibition	%	11.12
	8225056	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	13.38	CHEMBL6144	Homo sapiens	Inhibition	%	13.38
	8225190	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	1.19	CHEMBL6144	Homo sapiens	Inhibition	%	1.19
	8225414	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.55	CHEMBL6144	Homo sapiens	Inhibition	%	3.55
	8225552	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	3.19	CHEMBL6144	Homo sapiens	Inhibition	%	3.19
	8225911	CHEMBL1961880	GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.71	CHEMBL6144	Homo sapiens	Inhibition	%	2.71
	8226069	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.27	CHEMBL6144	Homo sapiens	Inhibition	%	-0.27
	8226418	CHEMBL1961881	GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	-4.58	CHEMBL6144	Homo sapiens	Inhibition	%	-4.58
	12046319	CHEMBL2156649	Inhibition of GRK6 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-8.6	CHEMBL6144	Homo sapiens	INH	%	-8.6
	12217982	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	106.0	CHEMBL6144	Homo sapiens	Residual Activity	%	106.0
	12217983	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	98.0	CHEMBL6144	Homo sapiens	Residual Activity	%	98.0
	12217984	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	98.0	CHEMBL6144	Homo sapiens	Residual Activity	%	98.0
	12217985	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	98.0	CHEMBL6144	Homo sapiens	Residual Activity	%	98.0
	12217986	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	95.0	CHEMBL6144	Homo sapiens	Residual Activity	%	95.0
	12217987	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12217988	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	96.0	CHEMBL6144	Homo sapiens	Residual Activity	%	96.0
	12217989	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	102.0	CHEMBL6144	Homo sapiens	Residual Activity	%	102.0
	12217990	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	103.0	CHEMBL6144	Homo sapiens	Residual Activity	%	103.0
	12217991	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	97.0	CHEMBL6144	Homo sapiens	Residual Activity	%	97.0
	12217992	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	95.0	CHEMBL6144	Homo sapiens	Residual Activity	%	95.0
	12217993	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	99.0	CHEMBL6144	Homo sapiens	Residual Activity	%	99.0
	12217994	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	97.0	CHEMBL6144	Homo sapiens	Residual Activity	%	97.0
	12217995	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	90.0	CHEMBL6144	Homo sapiens	Residual Activity	%	90.0
	12217996	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	100.0	CHEMBL6144	Homo sapiens	Residual Activity	%	100.0
	12217997	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	98.0	CHEMBL6144	Homo sapiens	Residual Activity	%	98.0
	12217998	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	101.0	CHEMBL6144	Homo sapiens	Residual Activity	%	101.0
	12217999	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	96.0	CHEMBL6144	Homo sapiens	Residual Activity	%	96.0
	12218000	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	90.0	CHEMBL6144	Homo sapiens	Residual Activity	%	90.0
	12218001	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	59.0	CHEMBL6144	Homo sapiens	Residual Activity	%	59.0
	12218002	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12218003	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	85.0	CHEMBL6144	Homo sapiens	Residual Activity	%	85.0
	12218004	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	105.0	CHEMBL6144	Homo sapiens	Residual Activity	%	105.0
	12218005	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	103.0	CHEMBL6144	Homo sapiens	Residual Activity	%	103.0
	12218006	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	95.0	CHEMBL6144	Homo sapiens	Residual Activity	%	95.0
	12218007	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	100.0	CHEMBL6144	Homo sapiens	Residual Activity	%	100.0
	12218008	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	88.0	CHEMBL6144	Homo sapiens	Residual Activity	%	88.0
	12218009	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	85.0	CHEMBL6144	Homo sapiens	Residual Activity	%	85.0
	12218010	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	85.0	CHEMBL6144	Homo sapiens	Residual Activity	%	85.0
	12218011	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	85.0	CHEMBL6144	Homo sapiens	Residual Activity	%	85.0
	12218012	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	96.0	CHEMBL6144	Homo sapiens	Residual Activity	%	96.0
	12218013	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	98.0	CHEMBL6144	Homo sapiens	Residual Activity	%	98.0
	12218014	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	100.0	CHEMBL6144	Homo sapiens	Residual Activity	%	100.0
	12218015	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	96.0	CHEMBL6144	Homo sapiens	Residual Activity	%	96.0
	12218016	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	95.0	CHEMBL6144	Homo sapiens	Residual Activity	%	95.0
	12218017	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	90.0	CHEMBL6144	Homo sapiens	Residual Activity	%	90.0
	12218018	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	89.0	CHEMBL6144	Homo sapiens	Residual Activity	%	89.0
	12218019	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	89.0	CHEMBL6144	Homo sapiens	Residual Activity	%	89.0
	12218020	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	103.0	CHEMBL6144	Homo sapiens	Residual Activity	%	103.0
	12218021	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	102.0	CHEMBL6144	Homo sapiens	Residual Activity	%	102.0
	12218022	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	102.0	CHEMBL6144	Homo sapiens	Residual Activity	%	102.0
	12218023	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	95.0	CHEMBL6144	Homo sapiens	Residual Activity	%	95.0
	12218024	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	90.0	CHEMBL6144	Homo sapiens	Residual Activity	%	90.0
	12218025	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	81.0	CHEMBL6144	Homo sapiens	Residual Activity	%	81.0
	12218026	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	87.0	CHEMBL6144	Homo sapiens	Residual Activity	%	87.0
	12218027	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	87.0	CHEMBL6144	Homo sapiens	Residual Activity	%	87.0
	12218028	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	95.0	CHEMBL6144	Homo sapiens	Residual Activity	%	95.0
	12218029	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	81.0	CHEMBL6144	Homo sapiens	Residual Activity	%	81.0
	12218030	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	104.0	CHEMBL6144	Homo sapiens	Residual Activity	%	104.0
	12218031	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	103.0	CHEMBL6144	Homo sapiens	Residual Activity	%	103.0
	12218032	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12218033	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	92.0	CHEMBL6144	Homo sapiens	Residual Activity	%	92.0
	12218034	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	78.0	CHEMBL6144	Homo sapiens	Residual Activity	%	78.0
	12218035	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	84.0	CHEMBL6144	Homo sapiens	Residual Activity	%	84.0
	12218036	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	99.0	CHEMBL6144	Homo sapiens	Residual Activity	%	99.0
	12218037	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	99.0	CHEMBL6144	Homo sapiens	Residual Activity	%	99.0
	12218038	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	111.0	CHEMBL6144	Homo sapiens	Residual Activity	%	111.0
	12218039	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	91.0	CHEMBL6144	Homo sapiens	Residual Activity	%	91.0
	12218040	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	99.0	CHEMBL6144	Homo sapiens	Residual Activity	%	99.0
	12218041	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	92.0	CHEMBL6144	Homo sapiens	Residual Activity	%	92.0
	12218042	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	90.0	CHEMBL6144	Homo sapiens	Residual Activity	%	90.0
	12218043	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	79.0	CHEMBL6144	Homo sapiens	Residual Activity	%	79.0
	12218044	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	94.0	CHEMBL6144	Homo sapiens	Residual Activity	%	94.0
	12218045	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	96.0	CHEMBL6144	Homo sapiens	Residual Activity	%	96.0
	12218046	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	94.0	CHEMBL6144	Homo sapiens	Residual Activity	%	94.0
	12218047	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	97.0	CHEMBL6144	Homo sapiens	Residual Activity	%	97.0
	12218048	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	97.0	CHEMBL6144	Homo sapiens	Residual Activity	%	97.0
	12218049	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	102.0	CHEMBL6144	Homo sapiens	Residual Activity	%	102.0
	12218050	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	90.0	CHEMBL6144	Homo sapiens	Residual Activity	%	90.0
	12218051	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12218052	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	95.0	CHEMBL6144	Homo sapiens	Residual Activity	%	95.0
	12218053	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	99.0	CHEMBL6144	Homo sapiens	Residual Activity	%	99.0
	12218054	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	87.0	CHEMBL6144	Homo sapiens	Residual Activity	%	87.0
	12218055	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	98.0	CHEMBL6144	Homo sapiens	Residual Activity	%	98.0
	12220420	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	100.0	CHEMBL6144	Homo sapiens	Residual Activity	%	100.0
	12220421	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	100.0	CHEMBL6144	Homo sapiens	Residual Activity	%	100.0
	12220422	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12220423	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	68.0	CHEMBL6144	Homo sapiens	Residual Activity	%	68.0
	12220424	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	104.0	CHEMBL6144	Homo sapiens	Residual Activity	%	104.0
	12220425	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	17.0	CHEMBL6144	Homo sapiens	Residual Activity	%	17.0
	12220426	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	108.0	CHEMBL6144	Homo sapiens	Residual Activity	%	108.0
	12220427	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	98.0	CHEMBL6144	Homo sapiens	Residual Activity	%	98.0
	12220428	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	102.0	CHEMBL6144	Homo sapiens	Residual Activity	%	102.0
	12220429	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	106.0	CHEMBL6144	Homo sapiens	Residual Activity	%	106.0
	12220430	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	95.0	CHEMBL6144	Homo sapiens	Residual Activity	%	95.0
	12220431	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	101.0	CHEMBL6144	Homo sapiens	Residual Activity	%	101.0
	12220432	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	105.0	CHEMBL6144	Homo sapiens	Residual Activity	%	105.0
	12220433	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	107.0	CHEMBL6144	Homo sapiens	Residual Activity	%	107.0
	12220434	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	100.0	CHEMBL6144	Homo sapiens	Residual Activity	%	100.0
	12220435	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	81.0	CHEMBL6144	Homo sapiens	Residual Activity	%	81.0
	12220436	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	98.0	CHEMBL6144	Homo sapiens	Residual Activity	%	98.0
	12220437	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	87.0	CHEMBL6144	Homo sapiens	Residual Activity	%	87.0
	12220438	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	76.0	CHEMBL6144	Homo sapiens	Residual Activity	%	76.0
	12220439	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12220440	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	99.0	CHEMBL6144	Homo sapiens	Residual Activity	%	99.0
	12220441	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	100.0	CHEMBL6144	Homo sapiens	Residual Activity	%	100.0
	12220442	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	100.0	CHEMBL6144	Homo sapiens	Residual Activity	%	100.0
	12220443	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	92.0	CHEMBL6144	Homo sapiens	Residual Activity	%	92.0
	12220444	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	96.0	CHEMBL6144	Homo sapiens	Residual Activity	%	96.0
	12220445	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	83.0	CHEMBL6144	Homo sapiens	Residual Activity	%	83.0
	12220446	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	82.0	CHEMBL6144	Homo sapiens	Residual Activity	%	82.0
	12220447	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	36.0	CHEMBL6144	Homo sapiens	Residual Activity	%	36.0
	12220448	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	99.0	CHEMBL6144	Homo sapiens	Residual Activity	%	99.0
	12220449	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	104.0	CHEMBL6144	Homo sapiens	Residual Activity	%	104.0
	12220450	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12220451	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	96.0	CHEMBL6144	Homo sapiens	Residual Activity	%	96.0
	12220452	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	100.0	CHEMBL6144	Homo sapiens	Residual Activity	%	100.0
	12220453	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	88.0	CHEMBL6144	Homo sapiens	Residual Activity	%	88.0
	12220454	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	89.0	CHEMBL6144	Homo sapiens	Residual Activity	%	89.0
	12220455	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	92.0	CHEMBL6144	Homo sapiens	Residual Activity	%	92.0
	12220456	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	102.0	CHEMBL6144	Homo sapiens	Residual Activity	%	102.0
	12220457	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	103.0	CHEMBL6144	Homo sapiens	Residual Activity	%	103.0
	12220458	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	105.0	CHEMBL6144	Homo sapiens	Residual Activity	%	105.0
	12220459	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	89.0	CHEMBL6144	Homo sapiens	Residual Activity	%	89.0
	12220460	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12220461	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	88.0	CHEMBL6144	Homo sapiens	Residual Activity	%	88.0
	12220462	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	85.0	CHEMBL6144	Homo sapiens	Residual Activity	%	85.0
	12220463	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	91.0	CHEMBL6144	Homo sapiens	Residual Activity	%	91.0
	12220464	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	98.0	CHEMBL6144	Homo sapiens	Residual Activity	%	98.0
	12220465	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	102.0	CHEMBL6144	Homo sapiens	Residual Activity	%	102.0
	12220466	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	98.0	CHEMBL6144	Homo sapiens	Residual Activity	%	98.0
	12220467	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	91.0	CHEMBL6144	Homo sapiens	Residual Activity	%	91.0
	12220468	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	90.0	CHEMBL6144	Homo sapiens	Residual Activity	%	90.0
	12220469	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	89.0	CHEMBL6144	Homo sapiens	Residual Activity	%	89.0
	12220470	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	68.0	CHEMBL6144	Homo sapiens	Residual Activity	%	68.0
	12220471	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	85.0	CHEMBL6144	Homo sapiens	Residual Activity	%	85.0
	12220472	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	103.0	CHEMBL6144	Homo sapiens	Residual Activity	%	103.0
	12220473	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	103.0	CHEMBL6144	Homo sapiens	Residual Activity	%	103.0
	12220474	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12220475	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	85.0	CHEMBL6144	Homo sapiens	Residual Activity	%	85.0
	12220476	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	95.0	CHEMBL6144	Homo sapiens	Residual Activity	%	95.0
	12220477	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	84.0	CHEMBL6144	Homo sapiens	Residual Activity	%	84.0
	12220478	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	87.0	CHEMBL6144	Homo sapiens	Residual Activity	%	87.0
	12220479	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	88.0	CHEMBL6144	Homo sapiens	Residual Activity	%	88.0
	12220480	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12220481	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	90.0	CHEMBL6144	Homo sapiens	Residual Activity	%	90.0
	12220482	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12220483	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	97.0	CHEMBL6144	Homo sapiens	Residual Activity	%	97.0
	12220484	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	89.0	CHEMBL6144	Homo sapiens	Residual Activity	%	89.0
	12220485	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12220486	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	86.0	CHEMBL6144	Homo sapiens	Residual Activity	%	86.0
	12220487	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	98.0	CHEMBL6144	Homo sapiens	Residual Activity	%	98.0
	12220488	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	100.0	CHEMBL6144	Homo sapiens	Residual Activity	%	100.0
	12220489	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	101.0	CHEMBL6144	Homo sapiens	Residual Activity	%	101.0
	12220490	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	95.0	CHEMBL6144	Homo sapiens	Residual Activity	%	95.0
	12220491	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	96.0	CHEMBL6144	Homo sapiens	Residual Activity	%	96.0
	12220492	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	86.0	CHEMBL6144	Homo sapiens	Residual Activity	%	86.0
	12220493	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	94.0	CHEMBL6144	Homo sapiens	Residual Activity	%	94.0
	12220494	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	97.0	CHEMBL6144	Homo sapiens	Residual Activity	%	97.0
	12220495	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	103.0	CHEMBL6144	Homo sapiens	Residual Activity	%	103.0
	12220496	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	101.0	CHEMBL6144	Homo sapiens	Residual Activity	%	101.0
	12220497	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	99.0	CHEMBL6144	Homo sapiens	Residual Activity	%	99.0
	12220498	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	97.0	CHEMBL6144	Homo sapiens	Residual Activity	%	97.0
	12220499	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	105.0	CHEMBL6144	Homo sapiens	Residual Activity	%	105.0
	12220500	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	98.0	CHEMBL6144	Homo sapiens	Residual Activity	%	98.0
	12220501	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	105.0	CHEMBL6144	Homo sapiens	Residual Activity	%	105.0
	12220502	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	109.0	CHEMBL6144	Homo sapiens	Residual Activity	%	109.0
	12220503	CHEMBL2219090	Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	108.0	CHEMBL6144	Homo sapiens	Residual Activity	%	108.0
	12220504	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	104.0	CHEMBL6144	Homo sapiens	Residual Activity	%	104.0
	12220505	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	68.0	CHEMBL6144	Homo sapiens	Residual Activity	%	68.0
	12220506	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	97.0	CHEMBL6144	Homo sapiens	Residual Activity	%	97.0
	12220507	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	92.0	CHEMBL6144	Homo sapiens	Residual Activity	%	92.0
	12220508	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	90.0	CHEMBL6144	Homo sapiens	Residual Activity	%	90.0
	12220509	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12220510	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	89.0	CHEMBL6144	Homo sapiens	Residual Activity	%	89.0
	12220511	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	99.0	CHEMBL6144	Homo sapiens	Residual Activity	%	99.0
	12220512	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	92.0	CHEMBL6144	Homo sapiens	Residual Activity	%	92.0
	12220513	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	96.0	CHEMBL6144	Homo sapiens	Residual Activity	%	96.0
	12220514	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	83.0	CHEMBL6144	Homo sapiens	Residual Activity	%	83.0
	12220515	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	80.0	CHEMBL6144	Homo sapiens	Residual Activity	%	80.0
	12220516	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	83.0	CHEMBL6144	Homo sapiens	Residual Activity	%	83.0
	12220517	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	83.0	CHEMBL6144	Homo sapiens	Residual Activity	%	83.0
	12220518	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	73.0	CHEMBL6144	Homo sapiens	Residual Activity	%	73.0
	12220519	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	94.0	CHEMBL6144	Homo sapiens	Residual Activity	%	94.0
	12220520	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12220521	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12220522	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	84.0	CHEMBL6144	Homo sapiens	Residual Activity	%	84.0
	12220523	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	68.0	CHEMBL6144	Homo sapiens	Residual Activity	%	68.0
	12220524	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	78.0	CHEMBL6144	Homo sapiens	Residual Activity	%	78.0
	12220525	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	81.0	CHEMBL6144	Homo sapiens	Residual Activity	%	81.0
	12220526	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	89.0	CHEMBL6144	Homo sapiens	Residual Activity	%	89.0
	12220527	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	91.0	CHEMBL6144	Homo sapiens	Residual Activity	%	91.0
	12220528	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	95.0	CHEMBL6144	Homo sapiens	Residual Activity	%	95.0
	12220529	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	90.0	CHEMBL6144	Homo sapiens	Residual Activity	%	90.0
	12220530	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	78.0	CHEMBL6144	Homo sapiens	Residual Activity	%	78.0
	12220531	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	78.0	CHEMBL6144	Homo sapiens	Residual Activity	%	78.0
	12220532	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	82.0	CHEMBL6144	Homo sapiens	Residual Activity	%	82.0
	12220533	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	59.0	CHEMBL6144	Homo sapiens	Residual Activity	%	59.0
	12220534	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	87.0	CHEMBL6144	Homo sapiens	Residual Activity	%	87.0
	12220535	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	94.0	CHEMBL6144	Homo sapiens	Residual Activity	%	94.0
	12220536	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	94.0	CHEMBL6144	Homo sapiens	Residual Activity	%	94.0
	12220537	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	92.0	CHEMBL6144	Homo sapiens	Residual Activity	%	92.0
	12220538	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	89.0	CHEMBL6144	Homo sapiens	Residual Activity	%	89.0
	12220539	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	81.0	CHEMBL6144	Homo sapiens	Residual Activity	%	81.0
	12220540	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	81.0	CHEMBL6144	Homo sapiens	Residual Activity	%	81.0
	12220541	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	83.0	CHEMBL6144	Homo sapiens	Residual Activity	%	83.0
	12220542	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	87.0	CHEMBL6144	Homo sapiens	Residual Activity	%	87.0
	12220543	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12220544	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	98.0	CHEMBL6144	Homo sapiens	Residual Activity	%	98.0
	12220545	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	91.0	CHEMBL6144	Homo sapiens	Residual Activity	%	91.0
	12220546	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	81.0	CHEMBL6144	Homo sapiens	Residual Activity	%	81.0
	12220547	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	34.0	CHEMBL6144	Homo sapiens	Residual Activity	%	34.0
	12220548	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	79.0	CHEMBL6144	Homo sapiens	Residual Activity	%	79.0
	12220549	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	83.0	CHEMBL6144	Homo sapiens	Residual Activity	%	83.0
	12220550	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	89.0	CHEMBL6144	Homo sapiens	Residual Activity	%	89.0
	12220551	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	86.0	CHEMBL6144	Homo sapiens	Residual Activity	%	86.0
	12220552	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	91.0	CHEMBL6144	Homo sapiens	Residual Activity	%	91.0
	12220553	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	88.0	CHEMBL6144	Homo sapiens	Residual Activity	%	88.0
	12220554	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	54.0	CHEMBL6144	Homo sapiens	Residual Activity	%	54.0
	12220555	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	73.0	CHEMBL6144	Homo sapiens	Residual Activity	%	73.0
	12220556	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	60.0	CHEMBL6144	Homo sapiens	Residual Activity	%	60.0
	12220557	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	51.0	CHEMBL6144	Homo sapiens	Residual Activity	%	51.0
	12220558	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	89.0	CHEMBL6144	Homo sapiens	Residual Activity	%	89.0
	12220559	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	88.0	CHEMBL6144	Homo sapiens	Residual Activity	%	88.0
	12220560	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	94.0	CHEMBL6144	Homo sapiens	Residual Activity	%	94.0
	12220561	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	90.0	CHEMBL6144	Homo sapiens	Residual Activity	%	90.0
	12220562	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	86.0	CHEMBL6144	Homo sapiens	Residual Activity	%	86.0
	12220563	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	77.0	CHEMBL6144	Homo sapiens	Residual Activity	%	77.0
	12220564	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	82.0	CHEMBL6144	Homo sapiens	Residual Activity	%	82.0
	12220565	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	70.0	CHEMBL6144	Homo sapiens	Residual Activity	%	70.0
	12220566	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	95.0	CHEMBL6144	Homo sapiens	Residual Activity	%	95.0
	12220567	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	88.0	CHEMBL6144	Homo sapiens	Residual Activity	%	88.0
	12220568	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	100.0	CHEMBL6144	Homo sapiens	Residual Activity	%	100.0
	12220569	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	90.0	CHEMBL6144	Homo sapiens	Residual Activity	%	90.0
	12220570	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	89.0	CHEMBL6144	Homo sapiens	Residual Activity	%	89.0
	12220571	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	84.0	CHEMBL6144	Homo sapiens	Residual Activity	%	84.0
	12220572	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	79.0	CHEMBL6144	Homo sapiens	Residual Activity	%	79.0
	12220573	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	88.0	CHEMBL6144	Homo sapiens	Residual Activity	%	88.0
	12220574	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	101.0	CHEMBL6144	Homo sapiens	Residual Activity	%	101.0
	12220575	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	94.0	CHEMBL6144	Homo sapiens	Residual Activity	%	94.0
	12220576	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	32.0	CHEMBL6144	Homo sapiens	Residual Activity	%	32.0
	12220577	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	97.0	CHEMBL6144	Homo sapiens	Residual Activity	%	97.0
	12220578	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	95.0	CHEMBL6144	Homo sapiens	Residual Activity	%	95.0
	12220579	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	80.0	CHEMBL6144	Homo sapiens	Residual Activity	%	80.0
	12220580	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	87.0	CHEMBL6144	Homo sapiens	Residual Activity	%	87.0
	12220581	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	17.0	CHEMBL6144	Homo sapiens	Residual Activity	%	17.0
	12220582	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	91.0	CHEMBL6144	Homo sapiens	Residual Activity	%	91.0
	12220583	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL6144	Homo sapiens	Residual Activity	%	-1.0
	12220584	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	95.0	CHEMBL6144	Homo sapiens	Residual Activity	%	95.0
	12220585	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	53.0	CHEMBL6144	Homo sapiens	Residual Activity	%	53.0
	12220586	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	89.0	CHEMBL6144	Homo sapiens	Residual Activity	%	89.0
	12220587	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	106.0	CHEMBL6144	Homo sapiens	Residual Activity	%	106.0
	12220588	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	103.0	CHEMBL6144	Homo sapiens	Residual Activity	%	103.0
	12220589	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	90.0	CHEMBL6144	Homo sapiens	Residual Activity	%	90.0
	12220590	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	99.0	CHEMBL6144	Homo sapiens	Residual Activity	%	99.0
	12220591	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	102.0	CHEMBL6144	Homo sapiens	Residual Activity	%	102.0
	12220592	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	101.0	CHEMBL6144	Homo sapiens	Residual Activity	%	101.0
	12220593	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	80.0	CHEMBL6144	Homo sapiens	Residual Activity	%	80.0
	12220594	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	80.0	CHEMBL6144	Homo sapiens	Residual Activity	%	80.0
	12220595	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	89.0	CHEMBL6144	Homo sapiens	Residual Activity	%	89.0
	12220596	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	65.0	CHEMBL6144	Homo sapiens	Residual Activity	%	65.0
	12220597	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	98.0	CHEMBL6144	Homo sapiens	Residual Activity	%	98.0
	12220598	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	100.0	CHEMBL6144	Homo sapiens	Residual Activity	%	100.0
	12220599	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	98.0	CHEMBL6144	Homo sapiens	Residual Activity	%	98.0
	12220600	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	87.0	CHEMBL6144	Homo sapiens	Residual Activity	%	87.0
	12220601	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	94.0	CHEMBL6144	Homo sapiens	Residual Activity	%	94.0
	12220602	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	85.0	CHEMBL6144	Homo sapiens	Residual Activity	%	85.0
	12220603	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	85.0	CHEMBL6144	Homo sapiens	Residual Activity	%	85.0
	12220604	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	75.0	CHEMBL6144	Homo sapiens	Residual Activity	%	75.0
	12220605	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	5.0	CHEMBL6144	Homo sapiens	Residual Activity	%	5.0
	12220606	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	96.0	CHEMBL6144	Homo sapiens	Residual Activity	%	96.0
	12220607	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	101.0	CHEMBL6144	Homo sapiens	Residual Activity	%	101.0
	12220608	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	95.0	CHEMBL6144	Homo sapiens	Residual Activity	%	95.0
	12220609	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	87.0	CHEMBL6144	Homo sapiens	Residual Activity	%	87.0
	12220610	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	79.0	CHEMBL6144	Homo sapiens	Residual Activity	%	79.0
	12220611	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	90.0	CHEMBL6144	Homo sapiens	Residual Activity	%	90.0
	12220612	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	91.0	CHEMBL6144	Homo sapiens	Residual Activity	%	91.0
	12220613	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	86.0	CHEMBL6144	Homo sapiens	Residual Activity	%	86.0
	12220614	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	94.0	CHEMBL6144	Homo sapiens	Residual Activity	%	94.0
	12220615	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	97.0	CHEMBL6144	Homo sapiens	Residual Activity	%	97.0
	12220616	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	94.0	CHEMBL6144	Homo sapiens	Residual Activity	%	94.0
	12220617	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	88.0	CHEMBL6144	Homo sapiens	Residual Activity	%	88.0
	12220618	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	80.0	CHEMBL6144	Homo sapiens	Residual Activity	%	80.0
	12220619	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	80.0	CHEMBL6144	Homo sapiens	Residual Activity	%	80.0
	12220620	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	74.0	CHEMBL6144	Homo sapiens	Residual Activity	%	74.0
	12220621	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	86.0	CHEMBL6144	Homo sapiens	Residual Activity	%	86.0
	12220622	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	97.0	CHEMBL6144	Homo sapiens	Residual Activity	%	97.0
	12220623	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	100.0	CHEMBL6144	Homo sapiens	Residual Activity	%	100.0
	12220624	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	90.0	CHEMBL6144	Homo sapiens	Residual Activity	%	90.0
	12220625	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	68.0	CHEMBL6144	Homo sapiens	Residual Activity	%	68.0
	12220626	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	53.0	CHEMBL6144	Homo sapiens	Residual Activity	%	53.0
	12220627	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	83.0	CHEMBL6144	Homo sapiens	Residual Activity	%	83.0
	12220628	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	72.0	CHEMBL6144	Homo sapiens	Residual Activity	%	72.0
	12220629	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	87.0	CHEMBL6144	Homo sapiens	Residual Activity	%	87.0
	12220630	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	82.0	CHEMBL6144	Homo sapiens	Residual Activity	%	82.0
	12220631	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	102.0	CHEMBL6144	Homo sapiens	Residual Activity	%	102.0
	12220632	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	96.0	CHEMBL6144	Homo sapiens	Residual Activity	%	96.0
	12220633	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	73.0	CHEMBL6144	Homo sapiens	Residual Activity	%	73.0
	12220634	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	86.0	CHEMBL6144	Homo sapiens	Residual Activity	%	86.0
	12220635	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	88.0	CHEMBL6144	Homo sapiens	Residual Activity	%	88.0
	12220636	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	81.0	CHEMBL6144	Homo sapiens	Residual Activity	%	81.0
	12220637	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	91.0	CHEMBL6144	Homo sapiens	Residual Activity	%	91.0
	12220638	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12220639	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	40.0	CHEMBL6144	Homo sapiens	Residual Activity	%	40.0
	12220640	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	85.0	CHEMBL6144	Homo sapiens	Residual Activity	%	85.0
	12220641	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	83.0	CHEMBL6144	Homo sapiens	Residual Activity	%	83.0
	12220642	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	86.0	CHEMBL6144	Homo sapiens	Residual Activity	%	86.0
	12220643	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	78.0	CHEMBL6144	Homo sapiens	Residual Activity	%	78.0
	12220644	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12220645	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	81.0	CHEMBL6144	Homo sapiens	Residual Activity	%	81.0
	12220646	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	91.0	CHEMBL6144	Homo sapiens	Residual Activity	%	91.0
	12220647	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	93.0	CHEMBL6144	Homo sapiens	Residual Activity	%	93.0
	12220648	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	88.0	CHEMBL6144	Homo sapiens	Residual Activity	%	88.0
	12220649	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	86.0	CHEMBL6144	Homo sapiens	Residual Activity	%	86.0
	12220650	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	88.0	CHEMBL6144	Homo sapiens	Residual Activity	%	88.0
	12220651	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	88.0	CHEMBL6144	Homo sapiens	Residual Activity	%	88.0
	12220652	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	97.0	CHEMBL6144	Homo sapiens	Residual Activity	%	97.0
	12220653	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	96.0	CHEMBL6144	Homo sapiens	Residual Activity	%	96.0
	12220654	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	76.0	CHEMBL6144	Homo sapiens	Residual Activity	%	76.0
	12220655	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	84.0	CHEMBL6144	Homo sapiens	Residual Activity	%	84.0
	12220656	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	94.0	CHEMBL6144	Homo sapiens	Residual Activity	%	94.0
	12223032	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	86.0	CHEMBL6144	Homo sapiens	Residual Activity	%	86.0
	12223033	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	90.0	CHEMBL6144	Homo sapiens	Residual Activity	%	90.0
	12223034	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	95.0	CHEMBL6144	Homo sapiens	Residual Activity	%	95.0
	12223035	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	97.0	CHEMBL6144	Homo sapiens	Residual Activity	%	97.0
	12223036	CHEMBL2219091	Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	105.0	CHEMBL6144	Homo sapiens	Residual Activity	%	105.0
	12728818	CHEMBL2352891	Inhibition of GRK6 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	102.0	CHEMBL6144	Homo sapiens	Activity	%	102.0
	12729063	CHEMBL2351969	Inhibition of GRK6 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	94.0	CHEMBL6144	Homo sapiens	Activity	%	94.0
	12729945	CHEMBL2352181	Inhibition of GRK6 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	97.0	CHEMBL6144	Homo sapiens	Activity	%	97.0
	12730206	CHEMBL2352891	Inhibition of GRK6 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	103.0	CHEMBL6144	Homo sapiens	Activity	%	103.0
	13375851	CHEMBL2405115	Inhibition of GRK6 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	6.0	CHEMBL6144	Homo sapiens	INH	%	6.0
	13872135	CHEMBL3101761	Inhibition of human GRK6 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	94.0	CHEMBL6144	Homo sapiens	Activity	%	94.0
	14582510	CHEMBL3242362	Inhibition of human GRK6 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	103.0	CHEMBL6144	Homo sapiens	Activity	%	103.0
	15018606	CHEMBL3366830	Inhibition of GRK6 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	4.5	CHEMBL6144	Homo sapiens	INH	%	4.5
	15756969	CHEMBL3630514	Inhibition of GRK6 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	-8.96	CHEMBL6144	Homo sapiens	INH	%	-8.96
	15757754	CHEMBL3630514	Inhibition of GRK6 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	-5.6	CHEMBL6144	Homo sapiens	INH	%	-5.6
	15758733	CHEMBL3630514	Inhibition of GRK6 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	-7.62	CHEMBL6144	Homo sapiens	INH	%	-7.62
	16362883	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	N#CC1=C(N)Oc2cc(N)ccc2C1c1cccs1		CHEMBL3715390	=	IC50	nM	11770.0	CHEMBL6144	Homo sapiens	IC50	uM	11.77
	16362884	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CCOc1cc(-c2ccc(O)c(O)c2)cc(=O)c2c(C)oc(C)c12		CHEMBL3716389	=	IC50	nM	4410.0	CHEMBL6144	Homo sapiens	IC50	uM	4.41
	16362885	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CCN=C(S)N(CCO)Cc1cc2cc3c(cc2nc1O)OCO3		CHEMBL1387051	>	IC50	nM	60000.0	CHEMBL6144	Homo sapiens	IC50	uM	60.0
	16362886	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=S(=O)(Nc1ccc(-n2cnnn2)cc1)c1ccc(S(=O)(=O)N2CCCCCC2)cc1		CHEMBL3716147	>	IC50	nM	60000.0	CHEMBL6144	Homo sapiens	IC50	uM	60.0
	16362887	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1coc(-c2ccccc2NS(=O)(=O)c2ccc(S(=O)(=O)N3CCCCCC3)cc2)c1		CHEMBL3718516	>	IC50	nM	60000.0	CHEMBL6144	Homo sapiens	IC50	uM	60.0
	16362888	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	N#CC1=C(N)Oc2cc(N)ccc2C1c1cc2cc3c(cc2nc1Cl)OCO3		CHEMBL3716327	=	IC50	nM	6480.0	CHEMBL6144	Homo sapiens	IC50	uM	6.48
	16362889	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CCn1c(COc2ccccc2)nnc1SCCC(=O)O		CHEMBL3717922	>	IC50	nM	60000.0	CHEMBL6144	Homo sapiens	IC50	uM	60.0
	16362890	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1nc2ccccn2c1-c1csc(Nc2ccc(N)cc2)n1		CHEMBL511583	>	IC50	nM	60000.0	CHEMBL6144	Homo sapiens	IC50	uM	60.0
	16362891	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CCOc1ccc(NC(c2ccccn2)c2ccc3cccnc3c2O)cc1		CHEMBL3714961	=	IC50	nM	4480.0	CHEMBL6144	Homo sapiens	IC50	uM	4.48
	16362892	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Oc1c(C(Nc2ccccn2)c2cccnc2)ccc2cccnc12		CHEMBL3715521	=	IC50	nM	6750.0	CHEMBL6144	Homo sapiens	IC50	uM	6.75
	16362893	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1ccc(NC(c2ccccn2)c2ccc3cccnc3c2O)cc1		CHEMBL3716299	=	IC50	nM	10260.0	CHEMBL6144	Homo sapiens	IC50	uM	10.26
	16362894	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1cccc(NC2=NC(=O)/C(=C/c3ccc(O)c(O)c3)S2)c1C		CHEMBL3717547	=	IC50	nM	7110.0	CHEMBL6144	Homo sapiens	IC50	uM	7.11
	16362895	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1cc(NC(c2ccccn2)c2ccc3cccnc3c2O)no1		CHEMBL1402572	=	IC50	nM	6450.0	CHEMBL6144	Homo sapiens	IC50	uM	6.45
	16362896	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CCN(CC)c1ccc(C2Nc3cccc4cccc(c34)N2)c(O)c1		CHEMBL1469355	=	IC50	nM	8440.0	CHEMBL6144	Homo sapiens	IC50	uM	8.44
	16362897	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Oc1ccc(-c2nc3ccc4ccccc4c3c3c2CCC3)cc1O		CHEMBL1560628	=	IC50	nM	28420.0	CHEMBL6144	Homo sapiens	IC50	uM	28.42
	16362898	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(/C=C2/SC(=S)N(c3cccnc3)C2=O)ccc1O		CHEMBL3715797	=	IC50	nM	40620.0	CHEMBL6144	Homo sapiens	IC50	uM	40.62
	16362899	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)c(O)c(O)c12		CHEMBL55415	=	IC50	nM	6610.0	CHEMBL6144	Homo sapiens	IC50	uM	6.61
	16362900	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CCOC(=O)c1ccc(CC(=O)c2ccc(O)c(O)c2O)o1		CHEMBL1313485	=	IC50	nM	7050.0	CHEMBL6144	Homo sapiens	IC50	uM	7.05
	16362901	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COC(=O)c1ccccc1-c1nnc(SCC(=O)O)[nH]1		CHEMBL3718129	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362902	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1cccc(-c2nnc(SCC(N)=O)[nH]2)c1		CHEMBL3717262	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362903	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2ccccc2C(=O)O)[nH]1		CHEMBL3717418	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362904	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	NC(=O)c1ccccc1-c1nnc(SCC(=O)O)[nH]1		CHEMBL3717446	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362905	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1cccc(-c2nnc(SC(C)C(=O)O)n2C)c1		CHEMBL3718843	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362906	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1cccc(-c2nnc(SCCC(=O)O)n2C)c1		CHEMBL3716832	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362907	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1cccc(-c2nnc(SCC(=O)O)n2C)c1		CHEMBL3718527	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362908	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1cccc(-c2nnc(SCC(=O)N(C)C)[nH]2)c1		CHEMBL3718283	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362909	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1cccc(Oc2ccc(-c3nnc(SCC(=O)O)[nH]3)cc2[N+](=O)[O-])c1		CHEMBL3715130	=	IC50	nM	3580.0	CHEMBL6144	Homo sapiens	IC50	uM	3.58
	16362910	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CC(=O)c1cccc(-c2nnc(SCC(=O)O)[nH]2)c1		CHEMBL3717649	=	IC50	nM	4110.0	CHEMBL6144	Homo sapiens	IC50	uM	4.11
	16362911	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cccc(-n3cncn3)c2)[nH]1		CHEMBL3716349	=	IC50	nM	4470.0	CHEMBL6144	Homo sapiens	IC50	uM	4.47
	16362912	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1ccc(O)c(-c2nnc(SCC(=O)O)[nH]2)c1		CHEMBL3717496	=	IC50	nM	4550.0	CHEMBL6144	Homo sapiens	IC50	uM	4.55
	16362913	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(-c2nnc(SCC(=O)O)[nH]2)ccc1F		CHEMBL3717118	=	IC50	nM	4520.0	CHEMBL6144	Homo sapiens	IC50	uM	4.52
	16362914	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cccc(-c3ccc4ccccc4c3)c2)[nH]1		CHEMBL3718518	=	IC50	nM	417.0	CHEMBL6144	Homo sapiens	IC50	uM	0.417
	16362915	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(Cl)cc(-c2cccc(-c3nnc(SCC(=O)O)[nH]3)c2)c1		CHEMBL3718739	=	IC50	nM	426.0	CHEMBL6144	Homo sapiens	IC50	uM	0.426
	16362916	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1ccc2cc(-c3cccc(-c4nnc(SCC(=O)O)[nH]4)c3)ccc2c1		CHEMBL3718989	=	IC50	nM	510.0	CHEMBL6144	Homo sapiens	IC50	uM	0.51
	16362917	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1ccc(-c2nnc(SCC(=O)O)[nH]2)cc1[N+](=O)[O-]		CHEMBL3716736	=	IC50	nM	751.0	CHEMBL6144	Homo sapiens	IC50	uM	0.751
	16362918	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cccc(-c3cccs3)c2)[nH]1		CHEMBL3717012	=	IC50	nM	757.0	CHEMBL6144	Homo sapiens	IC50	uM	0.757
	16362919	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	N#Cc1cccc(-c2cccc(-c3nnc(SCC(=O)O)[nH]3)c2)c1		CHEMBL3716413	=	IC50	nM	919.0	CHEMBL6144	Homo sapiens	IC50	uM	0.919
	16362920	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cc(Br)ccc2O)[nH]1		CHEMBL3715230	=	IC50	nM	1050.0	CHEMBL6144	Homo sapiens	IC50	uM	1.05
	16362921	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1ccc(-c2nnc(SCC(=O)O)[nH]2)cc1[N+](=O)[O-]		CHEMBL3715846	=	IC50	nM	1050.0	CHEMBL6144	Homo sapiens	IC50	uM	1.05
	16362922	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cccc([N+](=O)[O-])c2)[nH]1		CHEMBL3719304	=	IC50	nM	1400.0	CHEMBL6144	Homo sapiens	IC50	uM	1.4
	16362923	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	N#Cc1cccc(-c2nnc(SCC(=O)O)[nH]2)c1		CHEMBL3717328	=	IC50	nM	2310.0	CHEMBL6144	Homo sapiens	IC50	uM	2.31
	16362924	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(F)cc(-c2nnc(SCC(=O)O)[nH]2)c1		CHEMBL3718480	=	IC50	nM	2610.0	CHEMBL6144	Homo sapiens	IC50	uM	2.61
	16362925	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1ccc(O)c(-c2nnc(SCC(=O)O)[nH]2)c1		CHEMBL3716418	=	IC50	nM	2710.0	CHEMBL6144	Homo sapiens	IC50	uM	2.71
	16362926	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cccc(C(F)(F)F)c2)[nH]1		CHEMBL3717135	=	IC50	nM	3020.0	CHEMBL6144	Homo sapiens	IC50	uM	3.02
	16362927	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(-c2nnc(SCC(=O)O)[nH]2)cc(F)c1O		CHEMBL3715663	=	IC50	nM	3300.0	CHEMBL6144	Homo sapiens	IC50	uM	3.3
	16362928	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2ccc(F)c(F)c2)[nH]1		CHEMBL3715789	=	IC50	nM	3360.0	CHEMBL6144	Homo sapiens	IC50	uM	3.36
	16362929	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc([N+](=O)[O-])cc(-c2nnc(SCC(=O)O)[nH]2)c1O		CHEMBL3719063	=	IC50	nM	34800.0	CHEMBL6144	Homo sapiens	IC50	uM	34.8
	16362930	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CN(CCC#N)c1ccc(-c2nnc(SCC(=O)O)[nH]2)cc1		CHEMBL3718044	=	IC50	nM	35300.0	CHEMBL6144	Homo sapiens	IC50	uM	35.3
	16362931	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2ccc(N3CCCCC3)cc2F)[nH]1		CHEMBL3717247	=	IC50	nM	35700.0	CHEMBL6144	Homo sapiens	IC50	uM	35.7
	16362932	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(F)c(-c2nnc(SCC(=O)O)[nH]2)c(F)c1		CHEMBL3719184	=	IC50	nM	38500.0	CHEMBL6144	Homo sapiens	IC50	uM	38.5
	16362933	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CN(C)Cc1ccc(-c2nnc(SCC(=O)O)[nH]2)cc1		CHEMBL3715689	=	IC50	nM	40000.0	CHEMBL6144	Homo sapiens	IC50	uM	40.0
	16362934	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CN(C)c1ccc(-c2nnc(SCC(=O)O)[nH]2)c([N+](=O)[O-])c1		CHEMBL3716315	=	IC50	nM	40000.0	CHEMBL6144	Homo sapiens	IC50	uM	40.0
	16362935	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2ccc(OC3CCNCC3)cc2)[nH]1		CHEMBL3716062	=	IC50	nM	40000.0	CHEMBL6144	Homo sapiens	IC50	uM	40.0
	16362936	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1cc(C=O)c(O)c(-c2nnc(SCC(=O)O)[nH]2)c1		CHEMBL3718378	=	IC50	nM	45300.0	CHEMBL6144	Homo sapiens	IC50	uM	45.3
	16362937	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cccc(N3CCCCC3)c2)[nH]1		CHEMBL3718991	=	IC50	nM	51800.0	CHEMBL6144	Homo sapiens	IC50	uM	51.8
	16362938	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CSc1ccccc1-c1nnc(SCC(=O)O)[nH]1		CHEMBL3717477	=	IC50	nM	74100.0	CHEMBL6144	Homo sapiens	IC50	uM	74.1
	16362939	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1ccc([N+](=O)[O-])cc1-c1nnc(SCC(=O)O)[nH]1		CHEMBL3715432	=	IC50	nM	77500.0	CHEMBL6144	Homo sapiens	IC50	uM	77.5
	16362940	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cc(C(=O)O)ccc2F)[nH]1		CHEMBL3716532	=	IC50	nM	81700.0	CHEMBL6144	Homo sapiens	IC50	uM	81.7
	16362941	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1ccc(Br)cc1-c1nnc(SCC(=O)O)[nH]1		CHEMBL3718530	=	IC50	nM	87000.0	CHEMBL6144	Homo sapiens	IC50	uM	87.0
	16362942	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CN(C)c1ccc(-c2nnc(SCC(=O)O)[nH]2)cc1		CHEMBL3718517	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362943	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cccc(OC)c1-c1nnc(SCC(=O)O)[nH]1		CHEMBL3717611	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362944	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1ccc(-c2nnc(SCC(=O)O)[nH]2)c(Cl)c1OC		CHEMBL3716909	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362945	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cc(C(=O)O)ccc2O)[nH]1		CHEMBL3715687	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362946	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CN(C)CCCOc1ccccc1-c1nnc(SCC(=O)O)[nH]1		CHEMBL3716833	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362947	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)COc1ccccc1-c1nnc(SCC(=O)O)[nH]1		CHEMBL3717219	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362948	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CN1CCN(c2ccc(-c3nnc(SCC(=O)O)[nH]3)c(F)c2)CC1		CHEMBL3717807	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362949	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cccc(-c2nnc(SCC(=O)O)[nH]2)c1OC		CHEMBL3718593	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362950	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1ccc(-c2nnc(SCC(=O)O)[nH]2)c(OC)c1OC		CHEMBL3715065	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362951	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cccc(-c2nnc(SCC(=O)O)[nH]2)c1OCc1ccccc1		CHEMBL3719246	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362952	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(OC)c(-c2nnc(SCC(=O)O)[nH]2)cc1OC		CHEMBL3718560	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16362953	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cccc(-c3cnccn3)c2)[nH]1		CHEMBL3715220	=	IC50	nM	6500.0	CHEMBL6144	Homo sapiens	IC50	uM	6.5
	16362954	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cc(O)cc(O)c2)[nH]1		CHEMBL3716984	=	IC50	nM	6540.0	CHEMBL6144	Homo sapiens	IC50	uM	6.54
	16362955	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2ccc(O)c([N+](=O)[O-])c2)[nH]1		CHEMBL3718376	=	IC50	nM	6800.0	CHEMBL6144	Homo sapiens	IC50	uM	6.8
	16362956	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1ccc(-c2nnc(SCC(=O)O)[nH]2)c(O)c1		CHEMBL3717003	=	IC50	nM	6880.0	CHEMBL6144	Homo sapiens	IC50	uM	6.88
	16362957	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2ccc(O)c(F)c2)[nH]1		CHEMBL3717704	=	IC50	nM	7300.0	CHEMBL6144	Homo sapiens	IC50	uM	7.3
	16362958	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2ccc(-n3ccnc3)cc2)[nH]1		CHEMBL3718124	=	IC50	nM	7360.0	CHEMBL6144	Homo sapiens	IC50	uM	7.36
	16362959	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2ccc(-c3ccccc3)cc2)[nH]1		CHEMBL3716387	=	IC50	nM	7370.0	CHEMBL6144	Homo sapiens	IC50	uM	7.37
	16362960	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2ccc(-c3cncnc3)cc2)[nH]1		CHEMBL3718375	=	IC50	nM	7450.0	CHEMBL6144	Homo sapiens	IC50	uM	7.45
	16362961	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(-c2nnc(SCC(=O)O)[nH]2)cc(OC)c1OC		CHEMBL3717146	=	IC50	nM	8230.0	CHEMBL6144	Homo sapiens	IC50	uM	8.23
	16362962	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cccc(F)c2O)[nH]1		CHEMBL3715524	=	IC50	nM	8750.0	CHEMBL6144	Homo sapiens	IC50	uM	8.75
	16362963	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(-c2nnc(SCC(=O)O)[nH]2)ccc1OC(=O)C1CC1		CHEMBL3716382	=	IC50	nM	8830.0	CHEMBL6144	Homo sapiens	IC50	uM	8.83
	16362964	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(-c2nnc(SCC(=O)O)[nH]2)cc(OC)c1O		CHEMBL3715045	=	IC50	nM	8830.0	CHEMBL6144	Homo sapiens	IC50	uM	8.83
	16362965	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CCSc1ccc(-c2nnc(SCC(=O)O)[nH]2)cc1		CHEMBL3718452	=	IC50	nM	8840.0	CHEMBL6144	Homo sapiens	IC50	uM	8.84
	16362966	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COC(=O)c1ccc(-c2nnc(SCC(=O)O)[nH]2)cc1		CHEMBL3716214	=	IC50	nM	9560.0	CHEMBL6144	Homo sapiens	IC50	uM	9.56
	16362967	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(-c2nnc(SCC(=O)O)[nH]2)ccc1OC(C)=O		CHEMBL3715255	=	IC50	nM	9900.0	CHEMBL6144	Homo sapiens	IC50	uM	9.9
	16362968	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cccc(F)c2F)[nH]1		CHEMBL3718494	=	IC50	nM	10700.0	CHEMBL6144	Homo sapiens	IC50	uM	10.7
	16362969	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(F)c(-c2nnc(SCC(=O)O)[nH]2)cc1OC		CHEMBL3715884	=	IC50	nM	23700.0	CHEMBL6144	Homo sapiens	IC50	uM	23.7
	16362970	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cccc(N3CCNCC3)c2)[nH]1		CHEMBL3718691	=	IC50	nM	21900.0	CHEMBL6144	Homo sapiens	IC50	uM	21.9
	16362971	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1ccc(-c2nnc(SCC(=O)O)[nH]2)c(O)c1		CHEMBL3714864	=	IC50	nM	20900.0	CHEMBL6144	Homo sapiens	IC50	uM	20.9
	16362972	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(-c2nnc(SCC(=O)O)[nH]2)cc(O)c1OC		CHEMBL3717362	=	IC50	nM	20700.0	CHEMBL6144	Homo sapiens	IC50	uM	20.7
	16362973	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CNS(=O)(=O)c1cccc(-c2nnc(SCC(=O)O)[nH]2)c1		CHEMBL3715854	=	IC50	nM	18900.0	CHEMBL6144	Homo sapiens	IC50	uM	18.9
	16362974	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1ccc(F)c(-c2nnc(SCC(=O)O)[nH]2)c1		CHEMBL3715856	=	IC50	nM	18300.0	CHEMBL6144	Homo sapiens	IC50	uM	18.3
	16362975	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	C[S+]([O-])c1cccc(-c2nnc(SCC(=O)O)[nH]2)c1		CHEMBL3716558	=	IC50	nM	17500.0	CHEMBL6144	Homo sapiens	IC50	uM	17.5
	16362976	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cccc(Cn3cccn3)c2)[nH]1		CHEMBL3717776	=	IC50	nM	16200.0	CHEMBL6144	Homo sapiens	IC50	uM	16.2
	16363296	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(-c2nnc(SCC(=O)O)[nH]2)cc([N+](=O)[O-])c1O		CHEMBL3715971	=	IC50	nM	15900.0	CHEMBL6144	Homo sapiens	IC50	uM	15.9
	16363297	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2ccc(N3CCCC3=O)cc2)[nH]1		CHEMBL3714774	=	IC50	nM	15400.0	CHEMBL6144	Homo sapiens	IC50	uM	15.4
	16363298	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1cccc(-c2nnc(SCC(=O)O)[nH]2)c1		CHEMBL3716051	=	IC50	nM	1440.0	CHEMBL6144	Homo sapiens	IC50	uM	1.44
	16363299	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cc([N+](=O)[O-])ccc2O)[nH]1		CHEMBL3716148	=	IC50	nM	14100.0	CHEMBL6144	Homo sapiens	IC50	uM	14.1
	16363300	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1ccc(-c2nnc(SCC(=O)O)[nH]2)cc1O		CHEMBL3715383	=	IC50	nM	13300.0	CHEMBL6144	Homo sapiens	IC50	uM	13.3
	16363301	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2ccc(O)cc2O)[nH]1		CHEMBL3715051	=	IC50	nM	11600.0	CHEMBL6144	Homo sapiens	IC50	uM	11.6
	16363302	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CS(=O)(=O)c1cccc(-c2nnc(SCC(=O)O)[nH]2)c1		CHEMBL3716466	=	IC50	nM	6360.0	CHEMBL6144	Homo sapiens	IC50	uM	6.36
	16363303	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cc(O)ccc2O)[nH]1		CHEMBL3716535	=	IC50	nM	6160.0	CHEMBL6144	Homo sapiens	IC50	uM	6.16
	16363304	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cccc(F)c2)[nH]1		CHEMBL3716868	=	IC50	nM	4700.0	CHEMBL6144	Homo sapiens	IC50	uM	4.7
	16363305	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1ccc(-c2nnc(SCC(=O)O)[nH]2)cc1C		CHEMBL3716337	=	IC50	nM	4990.0	CHEMBL6144	Homo sapiens	IC50	uM	4.99
	16363306	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2ccc(O)c(O)c2)[nH]1		CHEMBL3717096	=	IC50	nM	5020.0	CHEMBL6144	Homo sapiens	IC50	uM	5.02
	16363307	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cccc(-c2nc(SCC(=O)O)n[nH]2)c1		CHEMBL1571373	=	IC50	nM	5850.0	CHEMBL6144	Homo sapiens	IC50	uM	5.85
	16363308	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(OC)cc(-c2nnc(SCC(=O)O)[nH]2)c1		CHEMBL3716367	=	IC50	nM	6100.0	CHEMBL6144	Homo sapiens	IC50	uM	6.1
	16363309	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cccc(O)c1-c1nnc(SCC(=O)O)[nH]1		CHEMBL3716228	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16363310	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc([N+](=O)[O-])ccc1-c1nnc(SCC(=O)O)[nH]1		CHEMBL3715704	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16363311	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COC(=O)CSc1nnc(-c2cccc(C)c2)[nH]1		CHEMBL3717975	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16363312	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(-c2nnc(SCC(=O)O)[nH]2)c([N+](=O)[O-])cc1OC		CHEMBL3716275	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16363313	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1c(F)cccc1-c1nnc(SCC(=O)O)[nH]1		CHEMBL3715640	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16363314	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cccc([N+](=O)[O-])c2O)[nH]1		CHEMBL3717243	>	IC50	nM	70000.0	CHEMBL6144	Homo sapiens	IC50	uM	70.0
	16363315	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cccc(C(=O)O)c2)[nH]1		CHEMBL3715149	>	IC50	nM	74000.0	CHEMBL6144	Homo sapiens	IC50	uM	74.0
	16363316	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1cccc(-c2nnc(SCCC(=O)O)[nH]2)c1		CHEMBL3717953	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16363317	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(N(C)C)ccc1-c1nnc(SCC(=O)O)[nH]1		CHEMBL3718727	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16363318	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1ccc(-c2nnc(SCC(=O)O)[nH]2)c(OC)c1C		CHEMBL3714870	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16363319	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2ccccc2OCCN2CCCC2)[nH]1		CHEMBL3716585	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16363320	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2ccccc2N2CCOCC2)[nH]1		CHEMBL3715706	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16363321	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CC(=O)CSc1nnc(-c2cccc(C)c2)[nH]1		CHEMBL3716296	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16363322	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1ccc(OC)c(-c2nnc(SCC(=O)O)[nH]2)c1		CHEMBL3717863	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16363323	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1cc(O)cc(OC)c1-c1nnc(SCC(=O)O)[nH]1		CHEMBL3715896	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	16363324	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CCN(CC)c1ccc(-c2nnc(SCC(=O)O)[nH]2)c(O)c1		CHEMBL3718611	=	IC50	nM	25800.0	CHEMBL6144	Homo sapiens	IC50	uM	25.8
	16363325	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	NC(=O)c1cc(N)c2c(c1N)C(=O)c1ccccc1C2=O		CHEMBL3717179	=	IC50	nM	12650.0	CHEMBL6144	Homo sapiens	IC50	uM	12.65
	16363326	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C1Nc2ccc(S(=O)(=O)N3CCCCC3)c3cccc1c23		CHEMBL3715967	>	IC50	nM	60000.0	CHEMBL6144	Homo sapiens	IC50	uM	60.0
	16363327	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1ccc(C2C(C#N)=C(N)Oc3cc(N)ccc32)cc1		CHEMBL1517037	=	IC50	nM	25960.0	CHEMBL6144	Homo sapiens	IC50	uM	25.96
	16363328	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CC(=O)Nc1ccc(Nc2nnc(-c3ccc(O)cc3)c3ccccc23)cc1		CHEMBL1336363	>	IC50	nM	60000.0	CHEMBL6144	Homo sapiens	IC50	uM	60.0
	16363329	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COCCNC(=O)CN(C(=O)c1snc(C(N)=O)c1N)c1ccccc1		CHEMBL3715400	>	IC50	nM	60000.0	CHEMBL6144	Homo sapiens	IC50	uM	60.0
	16363330	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CCOc1cccc(=O)c2c(C)[nH]c(C)c12		CHEMBL3719088	=	IC50	nM	2550.0	CHEMBL6144	Homo sapiens	IC50	uM	2.55
	16363331	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1cc2c(C(C)C)c(O)c(O)c(/C=N/CCCN3CCOCC3)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(/C=N/CCCN3CCOCC3)c2c1O		CHEMBL3717595	=	IC50	nM	10120.0	CHEMBL6144	Homo sapiens	IC50	uM	10.12
	16363332	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Nc1ccc2c3c1C(=O)OC3(O)c1ccccc1C2=O		CHEMBL3717080	=	IC50	nM	47000.0	CHEMBL6144	Homo sapiens	IC50	uM	47.0
	16363333	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NCCCN1CCOCC1)C(=O)C(O)=C3C(C)C)/C(=C/NCCCN1CCOCC1)C(=O)C(O)=C2C(C)C		CHEMBL3707013	=	IC50	nM	16890.0	CHEMBL6144	Homo sapiens	IC50	uM	16.89
	16363334	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CCN(CC)CCn1c2ccccc2c2cnc(N)c(C#N)c21		CHEMBL1573309	=	IC50	nM	18750.0	CHEMBL6144	Homo sapiens	IC50	uM	18.75
	16363335	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CCN(CC)c1ccc(C(c2c(C)n[nH]c2O)c2c(C)n[nH]c2O)cc1		CHEMBL3718841	=	IC50	nM	9930.0	CHEMBL6144	Homo sapiens	IC50	uM	9.93
	16363336	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CCOC(=O)c1c(N)n(C2CC2)c2nc3ccccc3nc12		CHEMBL3718269	=	IC50	nM	2830.0	CHEMBL6144	Homo sapiens	IC50	uM	2.83
	16363337	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CCCCC(CC)CNC(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Br)cc32)cc1		CHEMBL3718607	>	IC50	nM	60000.0	CHEMBL6144	Homo sapiens	IC50	uM	60.0
	16363338	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CN(C)c1ccc(O)c2c1CC1CC3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O		CHEMBL3716478	=	IC50	nM	1370.0	CHEMBL6144	Homo sapiens	IC50	uM	1.37
	16363339	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12		CHEMBL8260	=	IC50	nM	8700.0	CHEMBL6144	Homo sapiens	IC50	uM	8.7
	16363340	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1ccc([N+](=O)[O-])c(N[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1		CHEMBL3717069	=	IC50	nM	11950.0	CHEMBL6144	Homo sapiens	IC50	uM	11.95
	16363341	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CCOc1cccc(=O)c2c(C)n(-c3ccc(C)cc3)c(C)c12		CHEMBL3715401	=	IC50	nM	3400.0	CHEMBL6144	Homo sapiens	IC50	uM	3.4
	16363342	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1ccc(-c2cc(=O)oc3c(O)c(O)ccc23)cc1		CHEMBL1319645	=	IC50	nM	7160.0	CHEMBL6144	Homo sapiens	IC50	uM	7.16
	16363343	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	C=CCn1c(N)c(C(=O)OC)c2nc3ccccc3nc21		CHEMBL3717241	=	IC50	nM	973.0	CHEMBL6144	Homo sapiens	IC50	uM	0.973
	16363344	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CCCCn1c(N)c(C#N)c2nc3ccccc3nc21		CHEMBL590178	=	IC50	nM	1560.0	CHEMBL6144	Homo sapiens	IC50	uM	1.56
	16363345	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CCCCCn1c(N)c(C(=O)OC)c2nc3ccccc3nc21		CHEMBL3718188	=	IC50	nM	1030.0	CHEMBL6144	Homo sapiens	IC50	uM	1.03
	16363346	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CCCCCCn1c(N)c(C(=O)OC)c2nc3ccccc3nc21		CHEMBL607421	=	IC50	nM	1430.0	CHEMBL6144	Homo sapiens	IC50	uM	1.43
	16363347	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)c1ccc([C@@H]2Nc3ccc(I)cc3[C@@H]3C=CC[C@@H]32)cc1		CHEMBL3715181	=	IC50	nM	6660.0	CHEMBL6144	Homo sapiens	IC50	uM	6.66
	16363348	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=[N+]([O-])c1cc(C2=NN=C(NCc3ccco3)SC2)ccc1Cl		CHEMBL3718128	=	IC50	nM	6620.0	CHEMBL6144	Homo sapiens	IC50	uM	6.62
	16363349	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	c1ccc(-c2ccc(C3=NN=C(NCc4ccco4)SC3)cc2)cc1		CHEMBL3715525	=	IC50	nM	10440.0	CHEMBL6144	Homo sapiens	IC50	uM	10.44
	16363350	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Oc1ccc(-c2nnc(NCCc3ccccc3)s2)cc1		CHEMBL3718534	>	IC50	nM	60000.0	CHEMBL6144	Homo sapiens	IC50	uM	60.0
	16363351	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2ccc(OC(F)(F)F)cc2)[nH]1		CHEMBL3717039	=	IC50	nM	5920.0	CHEMBL6144	Homo sapiens	IC50	uM	5.92
	16363352	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=C(O)CSc1nnc(-c2cccs2)[nH]1		CHEMBL2159845	=	IC50	nM	4600.0	CHEMBL6144	Homo sapiens	IC50	uM	4.6
	16363353	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cc1ccc2nc(NC=O)sc2c1		CHEMBL3716179	>	IC50	nM	60000.0	CHEMBL6144	Homo sapiens	IC50	uM	60.0
	16363354	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Nc1ccc(CCc2nc3cc(N)ccc3o2)cc1		CHEMBL3717092	=	IC50	nM	17810.0	CHEMBL6144	Homo sapiens	IC50	uM	17.81
	16363355	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	C1=Nc2cccc3cccc(c23)N1		CHEMBL3717833	=	IC50	nM	12540.0	CHEMBL6144	Homo sapiens	IC50	uM	12.54
	16363356	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	COc1ccc(-c2cnc(-c3cccnc3)o2)cc1		CHEMBL1515025	>	IC50	nM	60000.0	CHEMBL6144	Homo sapiens	IC50	uM	60.0
	16363357	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	34000.0	CHEMBL6144	Homo sapiens	IC50	uM	34.0
	16363358	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21	Outside typical range	CHEMBL6291	=	IC50	nM	350000.0	CHEMBL6144	Homo sapiens	IC50	uM	350.0
	16363359	CHEMBL3721076	Inhibition of human recombinant full-length GST-tagged human GRK6 using peptide substrate peptide-216 incubated for 7 hrs	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12	Outside typical range	CHEMBL104264	=	IC50	nM	7000000.0	CHEMBL6144	Homo sapiens	IC50	uM	7000.0
	16375731	CHEMBL3734286	Inhibition of GRK6 (unknown origin) after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(OCc2ccccc2)c1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3727997	>	Ki	nM	10000.0	CHEMBL6144	Homo sapiens	Ki	nM	10000.0
	16375755	CHEMBL3734286	Inhibition of GRK6 (unknown origin) after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(C(=O)Nc2ccccc2)c1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3728662	>	Ki	nM	10000.0	CHEMBL6144	Homo sapiens	Ki	nM	10000.0
	16375756	CHEMBL3734286	Inhibition of GRK6 (unknown origin) after 90 to 120 mins by Kinase-Glo assay	B	COc1cccc(NCC(=O)N/N=C(\C)c2ccncc2)c1		CHEMBL3729044	>	Ki	nM	10000.0	CHEMBL6144	Homo sapiens	Ki	nM	10000.0
	16375757	CHEMBL3734286	Inhibition of GRK6 (unknown origin) after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(Oc2ccccc2)c1)N/N=C/c1ccncc1		CHEMBL3727728	>	Ki	nM	10000.0	CHEMBL6144	Homo sapiens	Ki	nM	10000.0
	16375758	CHEMBL3734286	Inhibition of GRK6 (unknown origin) after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(OCc2ccccc2)c1)N/N=C/c1ccncc1		CHEMBL3730555	>	Ki	nM	10000.0	CHEMBL6144	Homo sapiens	Ki	nM	10000.0
	16375759	CHEMBL3734286	Inhibition of GRK6 (unknown origin) after 90 to 120 mins by Kinase-Glo assay	B	COc1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3728772	>	Ki	nM	10000.0	CHEMBL6144	Homo sapiens	Ki	nM	10000.0
	16375760	CHEMBL3734286	Inhibition of GRK6 (unknown origin) after 90 to 120 mins by Kinase-Glo assay	B	NC(=O)c1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3729453	>	Ki	nM	10000.0	CHEMBL6144	Homo sapiens	Ki	nM	10000.0
	16375761	CHEMBL3734286	Inhibition of GRK6 (unknown origin) after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(Oc2ccccc2)c1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3731472	>	Ki	nM	10000.0	CHEMBL6144	Homo sapiens	Ki	nM	10000.0
	16375762	CHEMBL3734286	Inhibition of GRK6 (unknown origin) after 90 to 120 mins by Kinase-Glo assay	B	CNC(=O)c1cccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)c1		CHEMBL3729247	>	Ki	nM	10000.0	CHEMBL6144	Homo sapiens	Ki	nM	10000.0
	16375763	CHEMBL3734286	Inhibition of GRK6 (unknown origin) after 90 to 120 mins by Kinase-Glo assay	B	COc1cccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)c1		CHEMBL3732018	>	Ki	nM	10000.0	CHEMBL6144	Homo sapiens	Ki	nM	10000.0
	16425335	CHEMBL3751257	Inhibition of GRK6 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	4.7	CHEMBL6144	Homo sapiens	INH	%	4.7
	16431850	CHEMBL3748204	Inhibition of human GRK6 using casein as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL6144	Homo sapiens	IC50	uM	10.0
	16450860	CHEMBL3762716	Inhibition of GRK6 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	1.6	CHEMBL6144	Homo sapiens	INH	%	1.6
	16496007	CHEMBL3779702	Inhibition of N-terminal His6-tagged recombinant human GRK6 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-7.0	CHEMBL6144	Homo sapiens	Activity	%	-7.0
	16508194	CHEMBL3779702	Inhibition of N-terminal His6-tagged recombinant human GRK6 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-4.0	CHEMBL6144	Homo sapiens	Activity	%	-4.0
	16509171	CHEMBL3779702	Inhibition of N-terminal His6-tagged recombinant human GRK6 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	1.0	CHEMBL6144	Homo sapiens	Activity	%	1.0
	16614491	CHEMBL3816689	Inhibition of human GRK6 at 1 uM using casein as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	8.0	CHEMBL6144	Homo sapiens	INH	%	8.0
	16618203	CHEMBL3816351	Inhibition of full length recombinant human GST-tagged GRK6 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL6144	Homo sapiens	INH	%	50.0
	16837437	CHEMBL3876104	Inhibition of human recombinant full length GST-tagged GRK6 expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	10000.0	CHEMBL6144	Homo sapiens	IC50	nM	10000.0
Inactive	17904868	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904869	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904870	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904871	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904872	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904873	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904874	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904875	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904876	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904877	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904878	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904879	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904880	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904881	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904882	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904883	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904884	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904885	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904886	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904887	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904888	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904889	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904890	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904891	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904892	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904893	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904894	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904895	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904896	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904897	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904898	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904899	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904900	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904901	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904902	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904903	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904904	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904905	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904906	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904907	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904908	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904909	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904910	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904911	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904912	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904913	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904914	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904915	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904916	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904917	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904918	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904919	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904920	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904921	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904922	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904923	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904924	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904925	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904926	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904927	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904928	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904929	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904930	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904931	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904932	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904933	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904934	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904935	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904936	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904937	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904938	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904939	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904940	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17904941	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	13552.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	13552.0
Inactive	17904942	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904943	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904944	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904945	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904946	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904947	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904948	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904949	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904950	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904951	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904952	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904953	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904954	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904955	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904956	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904957	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904958	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904959	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17904960	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	1189.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	1189.0
Inactive	17904961	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904962	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904963	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904964	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904965	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904966	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904967	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904968	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904969	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904970	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904971	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904972	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904973	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904974	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904975	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904976	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904977	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17904978	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1615.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	1615.0
Inactive	17904979	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904980	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904981	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904982	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904983	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904984	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904985	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904986	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904987	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904988	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904989	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904990	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904991	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904992	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904993	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904994	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904995	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904996	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904997	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904998	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904999	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905000	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905001	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905002	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905003	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905004	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905005	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905006	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905007	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905008	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905009	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905010	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905011	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905012	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905013	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905014	CHEMBL3991725	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL6144	Homo sapiens	Kd apparent	nM	30000.0
	18184790	CHEMBL4040383	Inhibition of recombinant human full length GST-tagged GRK6 expressed in baculovirus using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	CNC(=O)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4095595	>	IC50	nM	30000.0	CHEMBL6144	Homo sapiens	IC50	nM	30000.0
	18184791	CHEMBL4040383	Inhibition of recombinant human full length GST-tagged GRK6 expressed in baculovirus using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4082775	>	IC50	nM	30000.0	CHEMBL6144	Homo sapiens	IC50	nM	30000.0
	18184792	CHEMBL4040383	Inhibition of recombinant human full length GST-tagged GRK6 expressed in baculovirus using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Cc1c(-c2ccncc2)n[nH]c1CNc1cccc(C(=O)NCc2ccccc2)c1		CHEMBL4065690	>	IC50	nM	30000.0	CHEMBL6144	Homo sapiens	IC50	nM	30000.0
	18184793	CHEMBL4040383	Inhibition of recombinant human full length GST-tagged GRK6 expressed in baculovirus using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncc1		CHEMBL1738877	>	IC50	nM	30000.0	CHEMBL6144	Homo sapiens	IC50	nM	30000.0
	18184794	CHEMBL4040383	Inhibition of recombinant human full length GST-tagged GRK6 expressed in baculovirus using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	CCn1c(CNc2cccc(C(=O)NCc3ccccc3)c2)nnc1-c1ccncc1		CHEMBL4083276	>	IC50	nM	30000.0	CHEMBL6144	Homo sapiens	IC50	nM	30000.0
	18184795	CHEMBL4040383	Inhibition of recombinant human full length GST-tagged GRK6 expressed in baculovirus using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1C(F)(F)F)c1cccc(NCc2nnc3n2CCOc2cnccc2-3)c1		CHEMBL4072828	>	IC50	nM	30000.0	CHEMBL6144	Homo sapiens	IC50	nM	30000.0
	18211637	CHEMBL4045687	Inhibition of GPRK6 conserved Lys2 (DLKPENILLDDHGHIR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-10.0	CHEMBL6144	Homo sapiens	INH	%	-10.0
	18211675	CHEMBL4045626	Inhibition of GPRK6 conserved Lys2 (DLKPENILLDDHGHIR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-25.8	CHEMBL6144	Homo sapiens	INH	%	-25.8
	18282086	CHEMBL4120041	Inhibition of recombinant full length GST-tagged human GRK6 expressed in baculovirus expression system at 1 uM by FRET relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	2.5	CHEMBL6144	Homo sapiens	INH	%	2.5
	18282405	CHEMBL4120041	Inhibition of recombinant full length GST-tagged human GRK6 expressed in baculovirus expression system at 1 uM by FRET relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	-4.2	CHEMBL6144	Homo sapiens	INH	%	-4.2
	18507772	CHEMBL4190990	Inhibition of recombinant full-length human GRK6 at 1 uM using casein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-3.0	CHEMBL6144	Homo sapiens	INH	%	-3.0
	18653617	CHEMBL4230095	Inhibition of GRK6 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	-9.0	CHEMBL6144	Homo sapiens	INH	%	-9.0
	18653618	CHEMBL4230095	Inhibition of GRK6 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	3.0	CHEMBL6144	Homo sapiens	INH	%	3.0
	18693990	CHEMBL4253443	Inhibition of recombinant human full length GST-tagged GRK6 expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	-4.0	CHEMBL6144	Homo sapiens	INH	%	-4.0
	18694072	CHEMBL4253525	Inhibition of recombinant human full length GST-tagged GRK6 expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	4.0	CHEMBL6144	Homo sapiens	INH	%	4.0
	18751101	CHEMBL4263813	Inhibition of GRK6 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	-1.0	CHEMBL6144	Homo sapiens	INH	%	-1.0
	18892880	CHEMBL4314846	Inhibition of recombinant full-length human GRK6 assessed as residual activity at 10 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	104.5	CHEMBL6144	Homo sapiens	Activity	%	104.5
	18937965	CHEMBL4327709	Inhibition of human GRK6 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	96.1	CHEMBL6144	Homo sapiens	Activity	%	96.1
	18937966	CHEMBL4327709	Inhibition of human GRK6 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	95.89	CHEMBL6144	Homo sapiens	Activity	%	95.89
	18938553	CHEMBL4328073	Inhibition of human GRK6 assessed as residual activity at 100 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL6144	Homo sapiens	Activity	%	65.0
	18938931	CHEMBL4328437	Inhibition of human GRK6 using casein as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	61.7	CHEMBL6144	Homo sapiens	IC50	10'-8M	6.17
	18964329	CHEMBL4335102	Inhibition of recombinant full length human GRK6 assessed as residual activity at 1 uM using casein as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	102.0	CHEMBL6144	Homo sapiens	Activity	%	102.0
	18964330	CHEMBL4335102	Inhibition of recombinant full length human GRK6 assessed as residual activity at 1 uM using casein as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	104.0	CHEMBL6144	Homo sapiens	Activity	%	104.0
	18971919	CHEMBL4336929	Inhibition of recombinant full length human GRK6 assessed as residual activity at 10 uM using casein as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	96.0	CHEMBL6144	Homo sapiens	Activity	%	96.0
Not Active	19039762	CHEMBL4351880	Inhibition of recombinant full-length human GRK6 at 10 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL6144	Homo sapiens	INH		
Active	19041128	CHEMBL4352389	Inhibition of human GRK6 at 10 uM using casein as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL6144	Homo sapiens	INH		
	19091946	CHEMBL4366420	Inhibition of human GRK6 at 100 nM using casein as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1	Outside typical range	CHEMBL4528675	=	Inhibition	%	-11.41	CHEMBL6144	Homo sapiens	INH	%	-11.41
	19144860	CHEMBL4377876	Inhibition of recombinant full-length human GRK6 at 1 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	5.0	CHEMBL6144	Homo sapiens	INH	%	5.0
	19147870	CHEMBL4379344	Inhibition of recombinant full length human GRK6 using casein as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL6144	Homo sapiens	IC50	uM	10.0
	19181042	CHEMBL4387253	Inhibition of recombinant full length human GST-tagged GRK6 expressed in baculovirus expression system at 0.1 uM using serine/threonine-16 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	6.0	CHEMBL6144	Homo sapiens	INH	%	6.0
	19181268	CHEMBL4387253	Inhibition of recombinant full length human GST-tagged GRK6 expressed in baculovirus expression system at 0.1 uM using serine/threonine-16 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	2.5	CHEMBL6144	Homo sapiens	INH	%	2.5
	19266442	CHEMBL4405392	Inhibition of GRK6 (unknown origin) at 1 uM relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL6144	Homo sapiens	INH	%	50.0
	19276049	CHEMBL4408052	Inhibition of recombinant human full length GRK6 at 1 uM using casein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	0.0	CHEMBL6144	Homo sapiens	INH	%	0.0
	19476575	CHEMBL4479723	Inhibition of full-length recombinant human GST-tagged GRK6 expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	17000.0	CHEMBL6144	Homo sapiens	IC50	nM	17000.0
	19476675	CHEMBL4479723	Inhibition of full-length recombinant human GST-tagged GRK6 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	nM	100000.0
	19476775	CHEMBL4479723	Inhibition of full-length recombinant human GST-tagged GRK6 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	500.0	CHEMBL6144	Homo sapiens	IC50	nM	500.0
	19476875	CHEMBL4479723	Inhibition of full-length recombinant human GST-tagged GRK6 expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	1700.0	CHEMBL6144	Homo sapiens	IC50	nM	1700.0
	20600541	CHEMBL4603493	Inhibition of recombinant full length human GST-tagged GRK6 expressed in baculovirus expression system using serine/threonine-16 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL6144	Homo sapiens	IC50	uM	100.0
	22392066	CHEMBL4667161	Inhibition of recombinant human GST-tagged full length GRK6 expressed in baculovirus expression system using Ser/Thr 16 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	-0.5	CHEMBL6144	Homo sapiens	INH	%	-0.5
	22423577	CHEMBL4674364	Inhibition of human GRK6 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	97.48	CHEMBL6144	Homo sapiens	Activity	%	97.48
	22423578	CHEMBL4674364	Inhibition of human GRK6 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	101.57	CHEMBL6144	Homo sapiens	Activity	%	101.57
	22768254	CHEMBL4703620	Inhibition of human GRK6	B	COc1cccc(Cn2cnc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4742990	=	IC50	nM	3270.0	CHEMBL6144	Homo sapiens	IC50	nM	3270.0
	22768255	CHEMBL4703620	Inhibition of human GRK6	B	COc1cccc(Cn2ncc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4744858	>	IC50	nM	10000.0	CHEMBL6144	Homo sapiens	IC50	nM	10000.0
	22843727	CHEMBL4720713	Inhibition of human GRK6 using casein as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	32.9	CHEMBL6144	Homo sapiens	IC50	10^-8M	3.29
	22844079	CHEMBL4721065	Inhibition of human GRK6 assessed as residual activity using casein as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	99.23	CHEMBL6144	Homo sapiens	Activity	%	99.23
	22844725	CHEMBL4721400	Inhibition of GRK6 (unknown origin) assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	95.62	CHEMBL6144	Homo sapiens	Activity	%	95.62
	22952854	CHEMBL4766791	Inhibition of recombinant full length human GRK6 assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	97.0	CHEMBL6144	Homo sapiens	Activity	%	97.0
	22994710	CHEMBL4775844	Inhibition of GRK6 (unknown origin) at 1 uM relative to control	B	C#CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(C(=O)N[C@H](C)c4ccccc4)cc32)c1C		CHEMBL4782014	=	Inhibition	%	94.0	CHEMBL6144	Homo sapiens	INH	%	94.0
	22994711	CHEMBL4775844	Inhibition of GRK6 (unknown origin) at 1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(C(=O)N[C@H](C)c4ccccc4)cc32)c(C)c1NC(=O)CBr		CHEMBL4785430	=	Inhibition	%	97.0	CHEMBL6144	Homo sapiens	INH	%	97.0
	23122291	CHEMBL4804723	Inhibition of GPRK6 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-40500.0	CHEMBL6144	Homo sapiens	IC50	uM	-40.5
	23122292	CHEMBL4804723	Inhibition of GPRK6 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	4700.0	CHEMBL6144	Homo sapiens	IC50	uM	4.7
	23122293	CHEMBL4804723	Inhibition of GPRK6 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	23100.0	CHEMBL6144	Homo sapiens	IC50	uM	23.1
	23122294	CHEMBL4804724	Inhibition of GPRK6 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL6144	Homo sapiens	INH	%	0.0
	23122295	CHEMBL4804724	Inhibition of GPRK6 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL6144	Homo sapiens	INH	%	0.0
	23122296	CHEMBL4804724	Inhibition of GPRK6 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL6144	Homo sapiens	INH	%	0.0
	23128140	CHEMBL4807855	Inhibition of GRK6 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL6144	Homo sapiens	Activity	%	75.0
	23128141	CHEMBL4807855	Inhibition of GRK6 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL6144	Homo sapiens	Activity	%	75.0
	23128142	CHEMBL4807855	Inhibition of GRK6 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL6144	Homo sapiens	Activity	%	75.0
	23150865	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)nc3ccccc23)n[nH]1		CHEMBL4848826	=	IC50	nM	120.0	CHEMBL6144	Homo sapiens	IC50	nM	120.0
	23150866	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCCc3ccc(F)cc3)nc3ccccc23)n[nH]1		CHEMBL4858397	=	IC50	nM	190.0	CHEMBL6144	Homo sapiens	IC50	nM	190.0
	23150867	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCCc3ccc(F)cc3)nc3cc(F)ccc23)n[nH]1		CHEMBL4848792	=	IC50	nM	180.0	CHEMBL6144	Homo sapiens	IC50	nM	180.0
	23150868	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCCc3ccc(F)cc3)nc3cc(Cl)ccc23)n[nH]1		CHEMBL4869307	=	IC50	nM	1100.0	CHEMBL6144	Homo sapiens	IC50	nM	1100.0
	23150869	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCCc3ccc(F)cc3)nc3ccc(F)cc23)n[nH]1		CHEMBL4856240	=	IC50	nM	310.0	CHEMBL6144	Homo sapiens	IC50	nM	310.0
	23150870	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCCc3ccc(F)cc3)nc3ccc(OC)cc23)n[nH]1		CHEMBL4875677	=	IC50	nM	460.0	CHEMBL6144	Homo sapiens	IC50	nM	460.0
	23150871	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCCc3ccc(F)cc3)nc3cccc(F)c23)n[nH]1		CHEMBL4876138	=	IC50	nM	110.0	CHEMBL6144	Homo sapiens	IC50	nM	110.0
	23150872	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCCc3ccccc3)nc3cccc(F)c23)n[nH]1		CHEMBL4876072	=	IC50	nM	20.0	CHEMBL6144	Homo sapiens	IC50	nM	20.0
	23150873	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCCc3ccccc3)nc3cccc(OC)c23)n[nH]1		CHEMBL4855000	=	IC50	nM	10.0	CHEMBL6144	Homo sapiens	IC50	nM	10.0
	23150874	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)nc3cc(F)ccc23)n[nH]1		CHEMBL4860927	=	IC50	nM	100.0	CHEMBL6144	Homo sapiens	IC50	nM	100.0
	23150875	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)nc3ccc(F)cc23)n[nH]1		CHEMBL4860226	=	IC50	nM	160.0	CHEMBL6144	Homo sapiens	IC50	nM	160.0
	23150876	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)nc3cc(Cl)ccc23)n[nH]1		CHEMBL4865487	=	IC50	nM	440.0	CHEMBL6144	Homo sapiens	IC50	nM	440.0
	23150877	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)nc3ccc(OC)cc23)n[nH]1		CHEMBL4860406	=	IC50	nM	140.0	CHEMBL6144	Homo sapiens	IC50	nM	140.0
	23150878	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)nc3cccc(F)c23)n[nH]1		CHEMBL4847311	=	IC50	nM	41.0	CHEMBL6144	Homo sapiens	IC50	nM	41.0
	23150879	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	Fc1cccc2nc(NCCc3ccccc3)nc(Nc3cc[nH]n3)c12		CHEMBL4875533	=	IC50	nM	2500.0	CHEMBL6144	Homo sapiens	IC50	nM	2500.0
	23150880	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	Fc1cccc2nc(NCCc3ccccc3)nc(Nc3ccon3)c12		CHEMBL4860235	>	IC50	nM	10000.0	CHEMBL6144	Homo sapiens	IC50	nM	10000.0
	23150881	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCn1cnc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)nc3cccc(F)c23)c1		CHEMBL4857672	=	IC50	nM	280.0	CHEMBL6144	Homo sapiens	IC50	nM	280.0
	23150882	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCOc1ccc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)nc3cccc(F)c23)cn1		CHEMBL4860810	>	IC50	nM	10000.0	CHEMBL6144	Homo sapiens	IC50	nM	10000.0
	23150883	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCc3ccc(F)cc3)nc3ccccc23)n[nH]1		CHEMBL4856820	=	IC50	nM	250.0	CHEMBL6144	Homo sapiens	IC50	nM	250.0
	23150884	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@H](C)c3ccc(F)cc3)nc3ccccc23)n[nH]1		CHEMBL4865763	=	IC50	nM	1400.0	CHEMBL6144	Homo sapiens	IC50	nM	1400.0
	23150885	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3cccc(F)c3)nc3ccccc23)n[nH]1		CHEMBL4869975	=	IC50	nM	340.0	CHEMBL6144	Homo sapiens	IC50	nM	340.0
	23150886	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(OC)cc3)nc3ccccc23)n[nH]1		CHEMBL4865412	=	IC50	nM	290.0	CHEMBL6144	Homo sapiens	IC50	nM	290.0
	23150887	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(Cl)cc3)nc3ccccc23)n[nH]1		CHEMBL4850937	=	IC50	nM	70.0	CHEMBL6144	Homo sapiens	IC50	nM	70.0
	23150888	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NC3(c4ccc(Cl)cc4)CC3)nc3ccccc23)n[nH]1		CHEMBL4876835	=	IC50	nM	280.0	CHEMBL6144	Homo sapiens	IC50	nM	280.0
	23150889	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(C)cc3)nc3cccc(F)c23)n[nH]1		CHEMBL4871944	=	IC50	nM	27.0	CHEMBL6144	Homo sapiens	IC50	nM	27.0
	23150890	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)nc3cccc(F)c23)n[nH]1		CHEMBL4870615	=	IC50	nM	29.0	CHEMBL6144	Homo sapiens	IC50	nM	29.0
	23150891	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(C#N)cn3)nc3cccc(F)c23)n[nH]1		CHEMBL4849245	=	IC50	nM	91.0	CHEMBL6144	Homo sapiens	IC50	nM	91.0
	23150892	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)nc3cccc(F)c23)n[nH]1		CHEMBL4875743	=	IC50	nM	230.0	CHEMBL6144	Homo sapiens	IC50	nM	230.0
	23150893	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3OC)nc3ccccc23)n[nH]1		CHEMBL4846282	=	IC50	nM	40.0	CHEMBL6144	Homo sapiens	IC50	nM	40.0
	23150894	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)C3CCCCC3)nc3ccccc23)n[nH]1		CHEMBL4860741	=	IC50	nM	960.0	CHEMBL6144	Homo sapiens	IC50	nM	960.0
	23150895	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCCN3CCOCC3)nc3cccc(F)c23)n[nH]1		CHEMBL4868574	=	IC50	nM	1400.0	CHEMBL6144	Homo sapiens	IC50	nM	1400.0
	23150896	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)nc3cccc(OC)c23)n[nH]1		CHEMBL4854871	=	IC50	nM	7.2	CHEMBL6144	Homo sapiens	IC50	nM	7.2
	23150897	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCc3ccc(F)cn3)nc3cccc(OC)c23)n[nH]1		CHEMBL4847703	=	IC50	nM	18.0	CHEMBL6144	Homo sapiens	IC50	nM	18.0
	23150898	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3)nc3cccc(OC)c23)n[nH]1		CHEMBL4874424	=	IC50	nM	16.0	CHEMBL6144	Homo sapiens	IC50	nM	16.0
	23150899	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3OC)nc3cccc(OC)c23)n[nH]1		CHEMBL4877302	=	IC50	nM	8.0	CHEMBL6144	Homo sapiens	IC50	nM	8.0
	23150900	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(Cl)cn3)nc3cccc(OC)c23)n[nH]1		CHEMBL4852125	=	IC50	nM	3.5	CHEMBL6144	Homo sapiens	IC50	nM	3.5
	23150901	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)nc3cccc(C)c23)n[nH]1		CHEMBL4875929	=	IC50	nM	11.0	CHEMBL6144	Homo sapiens	IC50	nM	11.0
	23150902	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3)nc3cccc(C)c23)n[nH]1		CHEMBL4872426	=	IC50	nM	27.0	CHEMBL6144	Homo sapiens	IC50	nM	27.0
	23150903	CHEMBL4810421	Inhibition of recombinant full-length human GRK6 using casein as substrate measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3OC)nc3cccc(C)c23)n[nH]1		CHEMBL4860332	=	IC50	nM	6.0	CHEMBL6144	Homo sapiens	IC50	nM	6.0
	23150904	CHEMBL4810422	Inhibition of recombinant full-length human GRK6 using casein as substrate at 1 uM measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method relative to control	B	N#CCc1ccc(Nc2nc(Nc3cc(C4CCC4)[nH]n3)c3ccccc3n2)cc1		CHEMBL4848399	=	Inhibition	%	95.0	CHEMBL6144	Homo sapiens	INH	%	95.0
	23150905	CHEMBL4810422	Inhibition of recombinant full-length human GRK6 using casein as substrate at 1 uM measured after 80 mins in presence of [gamma33P]ATP by radiometric scintillation counting method relative to control	B	Cc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)c(C#N)cc2F)n[nH]1		CHEMBL1774055	=	Inhibition	%	79.0	CHEMBL6144	Homo sapiens	INH	%	79.0
	23150961	CHEMBL4810444	Inhibition of human GRK6 using casein as substrate in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)nc3cccc(OC)c23)n[nH]1		CHEMBL4854871	=	IC50	nM	18.0	CHEMBL6144	Homo sapiens	IC50	nM	18.0
	23150962	CHEMBL4810444	Inhibition of human GRK6 using casein as substrate in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCc1cc(Nc2nc(NCc3ccc(F)cn3)nc3cccc(OC)c23)n[nH]1		CHEMBL4847703	=	IC50	nM	33.0	CHEMBL6144	Homo sapiens	IC50	nM	33.0
	23150963	CHEMBL4810444	Inhibition of human GRK6 using casein as substrate in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3OC)nc3cccc(OC)c23)n[nH]1		CHEMBL4877302	=	IC50	nM	3.8	CHEMBL6144	Homo sapiens	IC50	nM	3.8
	23150967	CHEMBL4810446	Binding affinity to FLAG-tagged GRK6 in human KMS11 cells incubated for 2.5 hrs by ITDR assay	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)nc3cccc(OC)c23)n[nH]1		CHEMBL4854871	=	IC50	nM	2000.0	CHEMBL6144	Homo sapiens	IC50	nM	2000.0
	23150968	CHEMBL4810446	Binding affinity to FLAG-tagged GRK6 in human KMS11 cells incubated for 2.5 hrs by ITDR assay	B	CCc1cc(Nc2nc(NCc3ccc(F)cn3)nc3cccc(OC)c23)n[nH]1		CHEMBL4847703	=	IC50	nM	10000.0	CHEMBL6144	Homo sapiens	IC50	nM	10000.0
	23150969	CHEMBL4810446	Binding affinity to FLAG-tagged GRK6 in human KMS11 cells incubated for 2.5 hrs by ITDR assay	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3)nc3cccc(OC)c23)n[nH]1		CHEMBL4874424	=	IC50	nM	2000.0	CHEMBL6144	Homo sapiens	IC50	nM	2000.0
	23150970	CHEMBL4810446	Binding affinity to FLAG-tagged GRK6 in human KMS11 cells incubated for 2.5 hrs by ITDR assay	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3OC)nc3cccc(OC)c23)n[nH]1		CHEMBL4877302	=	IC50	nM	30.0	CHEMBL6144	Homo sapiens	IC50	nM	30.0
	23150971	CHEMBL4810446	Binding affinity to FLAG-tagged GRK6 in human KMS11 cells incubated for 2.5 hrs by ITDR assay	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)nc3cccc(C)c23)n[nH]1		CHEMBL4875929	=	IC50	nM	610.0	CHEMBL6144	Homo sapiens	IC50	nM	610.0
	23150972	CHEMBL4810446	Binding affinity to FLAG-tagged GRK6 in human KMS11 cells incubated for 2.5 hrs by ITDR assay	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3OC)nc3cccc(C)c23)n[nH]1		CHEMBL4860332	=	IC50	nM	170.0	CHEMBL6144	Homo sapiens	IC50	nM	170.0
	23150973	CHEMBL4810447	Binding affinity to FLAG-tagged GRK6 in human KMS11 cells assessed as half life of GRK6 occupancy at 5 uM preincubated for 2.5 hrs followed by compound washout by ITDR assay	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3OC)nc3cccc(OC)c23)n[nH]1		CHEMBL4877302	=	T1/2	hr	25.0	CHEMBL6144	Homo sapiens	t1/2	hr	25.0
	23150974	CHEMBL4810447	Binding affinity to FLAG-tagged GRK6 in human KMS11 cells assessed as half life of GRK6 occupancy at 5 uM preincubated for 2.5 hrs followed by compound washout by ITDR assay	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)nc3cccc(C)c23)n[nH]1		CHEMBL4875929	<	T1/2	hr	1.0	CHEMBL6144	Homo sapiens	t1/2	hr	1.0
	23150975	CHEMBL4810447	Binding affinity to FLAG-tagged GRK6 in human KMS11 cells assessed as half life of GRK6 occupancy at 5 uM preincubated for 2.5 hrs followed by compound washout by ITDR assay	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3OC)nc3cccc(C)c23)n[nH]1		CHEMBL4860332	=	T1/2	hr	2.0	CHEMBL6144	Homo sapiens	t1/2	hr	2.0
Not Active	23324021	CHEMBL4880640	GRK6 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-2.0	CHEMBL6144	Homo sapiens	% inhibition	%	-2.0
Not Active	23329359	CHEMBL4881066	GRK6(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	111.0	CHEMBL6144	Homo sapiens	% residual kinase activity	%	111.0
Not Active	23337609	CHEMBL4881980	GRK6 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	101.5	CHEMBL6144	Homo sapiens	% Ctrl	%	101.5
Not Active	23352060	CHEMBL4882751	GRK6 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	6.633	CHEMBL6144	Homo sapiens	% Inhibition	%	6.6328
Not Active	23367586	CHEMBL4883939	GRK6 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	82.0	CHEMBL6144	Homo sapiens	% Residual activity with Skepinone-L	%	82.0
Not Active	23370081	CHEMBL4884325	GRK6(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	96.0	CHEMBL6144	Homo sapiens	% residual kinase activity	%	96.0
	23372756	CHEMBL4884721	GRK6(GRK6LGP1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL6144	Homo sapiens	pIC50		6.0
	23373165	CHEMBL4885012	GRK6(GRK6LGP1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL6144	Homo sapiens	pIC50		6.0
	23373526	CHEMBL4885303	GRK6(GRK6LGP1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL6144	Homo sapiens	pIC50		6.0
Not Active	23374990	CHEMBL4885983	GRK6 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	3.5	CHEMBL6144	Homo sapiens	% Inhibition	%	3.5
Not Active	23375259	CHEMBL4886241	G protein-coupled receptor kinase 6 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	3.0	CHEMBL6144	Homo sapiens	% inhibition	%	3.0
Not Active	23383805	CHEMBL4887440	GRK6 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	93.0	CHEMBL6144	Homo sapiens	% Ctrl	%	93.0
Not Active	23384289	CHEMBL4887884	GRK6(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	0.16	CHEMBL6144	Homo sapiens	% inhibition	%	0.16
Not Active	23384657	CHEMBL4888183	GRK6 SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	2.0	CHEMBL6144	Homo sapiens	% Inhibition	%	2.0
